LLY


Line plots across dimensions of each concept
Tables

Table of contents



us-gaap:CommonStockValue
us-gaap:StatementEquityComponents
us-gaap:SharesIssued

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare

us-gaap:Revenues
us-gaap:ProductOrService
us-gaap:ProductOrService, us-gaap:StatementGeographical
us-gaap:StatementGeographical

us-gaap:CostOfGoodsAndServicesSold

us-gaap:ResearchAndDevelopmentExpense

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:InterestExpense

us-gaap:OtherNonoperatingIncomeExpense
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome

us-gaap:NonoperatingIncomeExpense

us-gaap:IncomeTaxExpenseBenefit
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:StatementEquityComponents
us-gaap:ProfitLoss

us-gaap:ComprehensiveIncomeNetOfTax
us-gaap:StatementEquityComponents
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

us-gaap:NetIncomeLoss

us-gaap:Assets

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:ShortTermInvestments

us-gaap:AccountsReceivableNetCurrent

us-gaap:InventoryNet

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:LongTermInvestments
us-gaap:FairValueByMeasurementBasis

us-gaap:Goodwill
us-gaap:BusinessAcquisition

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:OtherAssetsNoncurrent

us-gaap:LiabilitiesCurrent

us-gaap:DebtCurrent

us-gaap:AccountsPayableCurrent

us-gaap:TaxesPayableCurrent

us-gaap:OtherLiabilitiesCurrent

us-gaap:DividendsPayableCurrent

us-gaap:LiabilitiesNoncurrent
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:LongTermDebt
us-gaap:FairValueByMeasurementBasis
us-gaap:LongtermDebtType

us-gaap:LongTermDebtNoncurrent

us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent

us-gaap:MinorityInterest

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:StockholdersEquity

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapitalCommonStock

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:TreasuryStockValue

us-gaap:MinorityInterest

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents
us-gaap:ProfitLoss

us-gaap:DepreciationDepletionAndAmortization

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:ProceedsFromIssuanceOfLongTermDebt

us-gaap:RepaymentsOfLongTermDebt
us-gaap:BusinessAcquisition

us-gaap:PaymentsOfDividends

us-gaap:PaymentsOfDividends

us-gaap:PaymentsForRepurchaseOfCommonStock

us-gaap:RepaymentsOfLongTermDebt
us-gaap:BusinessAcquisition

us-gaap:EffectiveIncomeTaxRateContinuingOperations

us-gaap:ShareBasedCompensation

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:ProceedsFromSaleOfShortTermInvestments

us-gaap:ProceedsFromSaleOfLongtermInvestments

lly:AcquiredInProcessResearchAndDevelopment
us-gaap:BusinessAcquisition

lly:AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain

lly:AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
lly:CollaborativeArrangementRightsAndObligationsTerms
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, dei:LegalEntity

lly:CostOfSalesOperatingExpensesAndOtherNet

lly:DerivativeInstrumentsGainLossRecognized

lly:ProceedsfromSaleofEquityandAvailableforSaleSecurities

lly:PurchasedInProcessResearchAndDevelopment
us-gaap:StatementGeographical, us-gaap:ChangeInAccountingEstimateByType
lly:RevenueInformationUsedToDetermineRevenueRecognizedChangeInAccountingEstimatePercent

us-gaap:AssetImpairmentCharges
us-gaap:BusinessAcquisition
us-gaap:BusinessAcquisition
us-gaap:BusinessCombinationConsiderationTransferred1

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanInterestCost
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanServiceCost

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:EquitySecuritiesFvNiGainLoss
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments

us-gaap:GainLossOnSaleOfBusiness
us-gaap:DisposalGroupClassification, us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperations

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
us-gaap:DisposalGroupClassification, us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperations
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

us-gaap:IncreaseDecreaseInDeferredIncomeTaxes

us-gaap:InvestmentIncomeInterest
us-gaap:LitigationCase, us-gaap:StatementGeographical
us-gaap:LossContingencyDamagesAwardedValue

us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment
us-gaap:DerivativeInstrumentRisk
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
us-gaap:DerivativeInstrumentRisk
us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment
us-gaap:StatementOperatingActivitiesSegment

us-gaap:OtherComprehensiveIncomeLossTax
us-gaap:StatementEquityComponents

us-gaap:OtherOperatingActivitiesCashFlowStatement

us-gaap:PaymentsForProceedsFromOtherInvestingActivities

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired

us-gaap:PaymentsToAcquireLongtermInvestments

us-gaap:PaymentsToAcquireProductiveAssets

us-gaap:PaymentsToAcquireShortTermInvestments

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities

us-gaap:ProceedsFromShortTermDebt

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents
us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment

us-gaap:RestructuringSettlementAndImpairmentProvisions

us-gaap:SeveranceCosts1
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
us-gaap:StatementEquityComponents
us-gaap:StockholdersEquityOther
us-gaap:StatementEquityComponents
us-gaap:TreasuryStockRetiredCostMethodAmount
us-gaap:StatementEquityComponents
us-gaap:TreasuryStockSharesAcquired
us-gaap:StatementEquityComponents
us-gaap:TreasuryStockSharesRetired
us-gaap:StatementEquityComponents
us-gaap:TreasuryStockValueAcquiredCostMethod

lly:DebtSecuritiesAvailableforsaleUnrealizedGainPosition
us-gaap:LitigationCase, us-gaap:SubsequentEventType
lly:LossContingencyNumberOfPatents

lly:SalesRebatesAndDiscounts

us-gaap:AccruedIncomeTaxesNoncurrent

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:CashAndCashEquivalentsFairValueDisclosure
us-gaap:FairValueByMeasurementBasis
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:CommercialPaper
us-gaap:FairValueByMeasurementBasis

us-gaap:CommonStockSharesHeldInEmployeeTrust

us-gaap:ContractWithCustomerLiability
us-gaap:ProductOrService

us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition

us-gaap:DeferredIncomeTaxAssetsNet

us-gaap:DeferredIncomeTaxLiabilitiesNet
us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlans
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsInFiveFiscalYearsThereafter
us-gaap:DerivativeInstrumentRisk
us-gaap:DerivativeAssetNotionalAmount
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeAssetsCurrent
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeAssetsNoncurrent
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeLiabilitiesCurrent
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeLiabilitiesNoncurrent
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk
us-gaap:DerivativeLiabilityNotionalAmount
us-gaap:DerivativeInstrumentRisk
us-gaap:DerivativeNotionalAmount
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

us-gaap:EmployeeRelatedLiabilitiesCurrent
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:FinancialInstrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByMeasurementBasis, us-gaap:FinancialInstrument
us-gaap:FairValueByMeasurementBasis
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
us-gaap:FairValueByMeasurementBasis, us-gaap:FinancialInstrument
us-gaap:OtherLongTermInvestments

us-gaap:OtherReceivablesNetCurrent

us-gaap:PrepaidExpenseCurrent

us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized

us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax

Tables

  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:CommonStockValue ▁▁▁▁▁▄▅▅▆▆▆▆▆▆▆▆▆▆▆▆▆▆▆▇▇▇▇▇▇███████598598600603607661667673680687688688690688690690690691693693694694696699700698704704704716725725725724724724NANANA
 us-gaap:SharesIssued us-gaap:StatementEquityComponents us-gaap:CommonStock▁▁▁▁▂▆▆▇▇███9569589609659711057106710771089110011011101NA1101NANANA1106NANANA1111NANANA1117NANANA1146NANANANANANANANANA
 us-gaap:SharesIssued us-gaap:StatementEquityComponents us-gaap:TreasuryStock▄▄▄▄▄▄▄▄▄▄▄▄000000000000NA0NANANA0NANANA0NANANA0NANANA2NANANANANANANANANA
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding 911NA918924984NA102610301049NA105610571056NA106010601063NA106510651067NA107410761075NA108410841091NANANANANANANANANANA
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic 908NA913920979NA102010301048NA105310551056NA105710571059NA106110611064NA106910711072NA108010801087NANANANANANANANANANA
us-gaap:EarningsPerShareBasic ▅▅▄▅█▄▄▃▄▁▃▄▃▄▄▄▃▃▄▄▃▃▃▄▄▄▄▄▅▄▄▄▄1.61.641.371.444.331.111.13-0.251.16-1.580.530.96-0.10.730.740.710.420.450.750.570.50.40.470.680.680.681.111.121.420.751.180.830.91NANANANANANA
us-gaap:EarningsPerShareDiluted ▅▅▅▅█▄▄▃▄▁▄▄▃▄▄▄▃▃▄▄▃▃▃▄▄▄▄▄▅▄▄▄▄1.61.641.371.444.311.11.12-0.251.16-1.580.530.95-0.10.730.730.710.410.450.750.560.50.40.470.680.680.671.111.111.420.741.180.830.91NANANANANANA
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare ██▇▇▄▆▆▁▆1.61.641.371.440.571.111.07-0.221.11NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare ██▇▇▄▆▆▁▆1.61.641.371.440.571.11.07-0.221.11NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:Revenues ▆▇▄▅▃█▇█▅▇▅▆▃▅▃▄▂▄▂▂▁▃▂▂▁▆▅▆▅▆▄▅▅▇▇▆▅▅▄585961145476563650926438606163555700616056585824522857605191540448655375495949784644512148754935468358085772592956025957544356005602614762525839565457485485
 us-gaap:Revenues us-gaap:ProductOrService lly:Diabetes2968NANANA2553NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService lly:Humalog695NA648677730NA664769791NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService lly:Oncology1201NA114711971012NA10641110956NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService lly:OtherProductTotal640NA303323421NA658784657NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService lly:TrulicityMember1229NA10111028879NA816779678NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService us-gaap:Product▅▆▃▄▁█▆▇▁▇▅▆540355344982516846926023566458994605582953235529NANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService,us-gaap:StatementGeographical lly:Diabetes,country:US1991NANANA1719NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService,us-gaap:StatementGeographical lly:Diabetes,us-gaap:NonUs977NANANA833NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService,us-gaap:StatementGeographical lly:Oncology,country:US▇█▆█▄▇▅▅▁657684640689593662619611510NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:ProductOrService,us-gaap:StatementGeographical lly:TrulicityMember,country:US██▅▅▃▄▃▂▁929942755792665729645612528NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:StatementGeographical country:JP▄█▅▆▂▆▄▆▂▆▅▅▁592709641653543664608664555652616627522NANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:StatementGeographical country:US▅▇▃▄▁█▆▇▃▆▃▅▁3328351930603252289036643446360231543423310433232933NANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:StatementGeographical lly:OtherForeignCountries▁▅▅▄▄█▇█▇█▆▆▆61087285180275710219899989541019920909875NANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:StatementGeographical srt:Europe▇▆▃▃▂█▆█▁▇▆▄1061101392392890010881017109086410651017963NANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Revenues us-gaap:StatementGeographical us-gaap:NonUs▇█▅▄▁▄▂▄25312594241623842201235422362342NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:CostOfGoodsAndServicesSold ▂▃▂▁▁▇▆█▆▇▇▆▄1215128211751124113815931562170215711644158615711347NANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ResearchAndDevelopmentExpense ▆█▅▆▃▆▅▅▃▇▅▄▄▆▄▅▃▆▂▃▁▃▄▃▂1392158113801402123014531343133311761473131912501238145012361335122114441143116910391185124311951109NA137713301348NA134213201151128012601124121911871039
us-gaap:SellingGeneralAndAdministrativeExpense ▃▅▁▄▃█▄▅▂▇▃▆▃▇▃▄▂▇▄▄▃▇▅▅▂1549169814121586151718611616165315001780155517071544179015651622147317981575163515231799167216631484NA165218671652NA175719311847191720431785169417551614
us-gaap:InterestExpense ▆▇██▆▅▄▄▃▄▃▃▂▂▂▂▂▂▁▁▁▁▁▁▁9295107110867869636162615346514743434439364037383537NA394040NA474345454545474747
us-gaap:OtherNonoperatingIncomeExpense ▅█▂▂▄▁▁▂▃▄▂▂▃▃▃▃▄▄▅▄▅▆▅▄▄12223613986-47-4152665212293545407465104591121501025559NA-232250NA220-26-60-3019918111
 us-gaap:OtherNonoperatingIncomeExpense us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:StatementEquityComponents us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome,us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterest▁▂▂▂▂▇▇██131414141418181919NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest ██▇▇▄▅▇▁▇▂▃▆▁▅▅▅▃▃▅▄▄▃▄▅▅16791663140514657319381411414412845911260618929709445664441047679617513655940890NA151315141951NA18741185133515021531NANANANA
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest ██▇▇▄▆▆▁▇145614951253132756111211093-2311167NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:NonoperatingIncomeExpense ▃▄▂▂▃▂▂▂▃▃▂▂▂▂▂▂▁▂▃▁▃▃▃▃▃▂▂▂▆▂█▂▂▁▂▂▂▂▃89262-24-3286-15-15386755-13-315152721-1494486-123921379353569-3111529-52788-16-46-83-57-11-21-1874
us-gaap:IncomeTaxExpenseBenefit ▂▂▂▂▂▁▂▂▂█▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂223167151138170-186261264223194136252172120192196126-33248788885154206162NA310308403NA548262324266334218368387459
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:NoncontrollingInterest█▅▃▂▇▃▁▃▂▆▂26124-1224-540160NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▅▅▄▅█▄▄▃▄▁▄1456149512531327424111251149-2591217-1656555NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ComprehensiveIncomeNetOfTax 1094NA111914144294NA1809-9311603NA723129287-196891641756564535855-136-1011-115755773NA158712711330NA17245381320740137615372080818943
us-gaap:NetIncomeLoss ▅▅▄▅█▄▄▃▄▁▄▄▃▄▄▄▃▄▄▄▄▃▄▄▄▄▄▄▅▄▅▄▄▄▄▄▅▅▄1456149512531327424111251149-2591217-16565551008-11077177874744047879960052942850073372772712031206154882713269231011123611971055130213481248
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:Assets ▆▅▄▅▄▇█▇██▇▆▄▅▄▄▃▃▃▃▃▄▃▃▃▃▂▂▁▂▂▁▁▂▂▁411023928637893386663800643908446254235944355449814301040946376243880537590364753469135568363043603635653371783464835018347563524833965332263230034398343213181232238330423277931695NANANA
us-gaap:LiabilitiesAndStockholdersEquity ▆▅▄▅▄▇█▇██▇▆▄▅▄▄▃▃▃▃▃▄▃▃▃▃▂▂▁▂▂▁▁▂▂▁411023928637893386663800643908446254235944355449814301040946376243880537590364753469135568363043603635653371783464835018347563524833965332263230034398343213181232238330423277931695NANANA
us-gaap:StockholdersEquity ▁▁▁▁▁▄▆▅▆▅▆▆▆▆▇▆▇▆▇▆▆▇████3078260633822780248098281307611555145271159214890141001403114007155891463715009145711522114670149191537317669179831833817631NANANA14765NANANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:AssetsCurrent ▃▃▂▂▂██▆▅▇▅▄▂▄▂▂▁▂▂▁▁▁▁▂▂▂▂▂▁▂▃▁▂▃▄▄139941370912661134541259720549206851833216261192021742815746129761510113385129771171412573125671234611742121791211013156130391310413202126391232613038140381230712602145721495015354NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue ▁█16992337NA229020367998896068173084653637243069261645823489323823073666323833153064387131653765388838304368378639364018531943454122659761136506590851634725
us-gaap:ShortTermInvestments ▁▁▁▁▁▁▁▁▅▄█▆▃▄▂▂▂▃▃▃▃▃▄▄▄▄▃▃▃▅▄▃▃▁▁▁78101897710088769217051497321823648881456737696687785108091510759551644136013241567101092479516651580915802186216206NANANA
us-gaap:AccountsReceivableNetCurrent █▆▅▆▅█▇▇▆▆▅▅▄▄▄▄▃▃▂▂▁▂▁▂▁▂▂▃▂▂▂▂▂▃▄▃510645474441461242005246485948234495454644014349401740293848394736223513340133483142323430533187300234343445357934393336326831813402353338333694NANANA
us-gaap:InventoryNet ▃▄▃▄▃▆▆▇█▇▇▇▆▅▆▅▅▄▄▄▃▂▃▄▃▃▃▂▂▂▂▁▁▂▃▂310231903101318130554111411841554631445844064346403535613881375937403445341732882980274028443190296929282974272525762643255323202424251328702767NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment ▇▇▇▆▆████▇▇▆▆▅▆▆▆▆▅▅▅▄▄▄▄▃▃▃▃▂▃▂▂▂▁▁914191619055895687929544967195669539926491328950871185258985886187508607853683818262806580388012780876717575740172647157730570857011680667166572NANANA
us-gaap:PropertyPlantAndEquipmentNet ▂▂▂▂▂█▇▇█▇▆▆▅▄▄▃▃▃▃▃▃▃▃▄▃▃▂▁▁▂▁▁▂▂▃▃789778727801784777808919881487708958882685988582842582528251806680338053807580227950796380438100797079757767763676237760763876197754781279537967NANANA
us-gaap:LongTermInvestments ▁▁▁▁▁▁▁▁▅▆▆▆▅▅▅▄▃▃▄▄▄▄█▇▇██▇▆▆▅▄▄▃▂▁214819621825185221112020200520595375567861485723529752075027444937643646410240994576456874056649720476247220656156366313522445474521321929431898NANANA
 us-gaap:LongTermInvestments us-gaap:FairValueByMeasurementBasis us-gaap:CarryingReportedAmountFairValueDisclosure▂▁▁▁▂▁▁▁▇█2148196218251852211120202005205953755678NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:Goodwill ▆▆▆▆▇███████▇▇▇▇▇▇▇▇▇▁3779367937723820385543474358433344124370436542904188397240074026404540394054402439461758NANANA1516NANANA1501NANANANANANANANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill █▆▆▆▆▂▂▂▂▃▃▃▄▃▄▄▄▄▃▄▄▁7766661866896586664135213619377239204029427145424716435746384806488950344615484249472884NANANA2814NANANANANANANANANANANANANA
us-gaap:OtherAssetsNoncurrent █▇▅▄▄▃▄▃▃▇▅▄▄▃▅▄▅▅▇▇▆▅▅▆▅▅▁▃▄▆▅▅▄▅▄▃304428712194205219631892200917761746287421972060202019132279214922442220288927012489241723382441233922121320188020952534238721952093221519761743NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:LiabilitiesCurrent ▆▆▅▆▅▆▅▇▅█▆▅▄▅▃▃▂▂▃▂▃▅▂▂▁▃▂▃▂▃▁▁▁▂▃▂126101177510828118551123611888108261305511547145351266611294104481098682728401734082298303823283421120775747417663189168076840875938389696066096553821986207651NANANA
us-gaap:DebtCurrent ▇▄▄▅▅▃▃▇▅██▆▆▅▂▂▂▁▁▁▃▆▂▁▁▃▃324814991563206823541131100230492304370635382444260919376416456486910805268831310910121019NANA11NANANANANANANANANA
us-gaap:AccountsPayableCurrent ▅█▃▅▄█▆▆▆█▅▆▅▇▄▅▄▇▄▄▄▃▂▃▄▃▅▄▁▄▇▅▅▄▄▄12071405111411981168141212811316126714101200125712201349116112071151133811791153117911281023112411491119124711419741188132812011246115411871183NANANA
us-gaap:TaxesPayableCurrent █▂▂▃▆▅▅▅█▆▅▃▁▁▂▁▁▄█66716018022249140440946469353241423612211918388114358700NANA93NANANA254NANANA143NANANA144183315NANANA
us-gaap:OtherLiabilitiesCurrent ▃▃▁▃▃▃▂▃▄█▄▂▃▃▁▃▃▅▂▆▅▅▂▁▄▄▂▄▃▇█▆▇▇█▆221721891988218922542213214621902346283223602112223222202001220022762460209926252516247220602036233023282110229722742738281625902754272027862600NANANA
us-gaap:DividendsPayableCurrent ▁█▁▇▁█▁▇▁▇▁▇▁▇▁▇▁▇▁▇▁▇▁▆▁▆▁▆▁▇▁▇▁▁▇▁0671059306500578059005470548053705390529053005240523052705410543005420NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:LiabilitiesNoncurrent ██▇▇█▆▆▅▅▅▄▄▃▃▃▃▃▃▃▃▃▂▁▁▁▁▁▁▁▂▂▂▂▁▂▂252952481123602239532420521111196471768318220187771538315482130721373813701134181232112749127601309912364105829391960697768691899395819750112351130310895108619765988110109NANANA
 us-gaap:LongTermDebt us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementBasis us-gaap:FairValueInputsLevel2,us-gaap:EstimateOfFairValueFairValueDisclosure████▇▅▅▂▃▄▄▄▁▂▂▂15119151501521914833142381246112542100631058311529114481131887609419100649926NA8172NANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:FairValueByMeasurementBasis us-gaap:CarryingReportedAmountFairValueDisclosure█████▆▆▃▃▄▄▄▁▂▂▂139871382313667137271361512272122779771102031095010938108878447900593489331NA7978NANANA5340NANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:FairValueByMeasurementBasis us-gaap:EstimateOfFairValueFairValueDisclosure████▇▅▅▂▃▄▄▄▁▂▂▂15119151501521914833142381246112542100631058311529114481131887609419100649926NA8172NANANA5722NANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:LongtermDebtType lly:ForeignCurrencyDenominatedDebt██▁▁▁▁▂▁▃▂▂▂▁▁▂543054903280338033303400345034003810370036703610342033403550NANA2270NANANANANANANANANANANANANANANANANANANANANA
us-gaap:LongTermDebtNoncurrent █████▆▆▅▅▅▅▅▃▄▄▄▃▄▄▄▃▂▂▂▂▁▁▁▁▂▂▂▂▂▂▂1398213817136621371713610116391167491709393994099269867763783678707868574777972806979887415536752925301525542004263429044315519551055005403545152005132NANANA
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent ██▄▅▅▅▅▇▇▇▄▄▄▄▃▃▃▃▄▅▄▄▁▁▁▁▄▅▅▆▅▅▅▂▂▂363236982414272327572911268434203505351324582465245524532077202021062160235826292520256215241528155315492607262126603012270227142766180518481866NANANA
us-gaap:MinorityInterest ▂▂▂▂▂██▁▁▂▂▂▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁118927976841080107465607570687272261819191935261413111099978-7-2-11-20-3NANANA
us-gaap:OtherLiabilitiesNoncurrent ▄▁▁▁▂█▃▃▃▃▆▆▆▆▅▄▄▄▃▃▃▃▃▄▅▄▂▂▂▂▄▃▃▃▃▄187310141100114211692835154715851574154622882443228222282111190718291747142214541474165316421836206118631268125812951369181514721533144915501886NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:StockholdersEquity ▁▁▁▁▁▄▆▅▆▅▆▆▆▆▇▆▇▆▇▆▆▇████3078260633822780248098281307611555145271159214890141001403114007155891463715009145711522114670149191537317669179831833817631NANANA14765NANANANANANANANANA
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ▁▁▁▁▁▅▆▅▆▅▆▆▆▆▇▆▇▆▇▆▆▇████▇▇▆▆▇▆▆▇▆▆3197269934622857256510909141501162014587116671496014169141031408015615146561502914590152401470514946153881768217994183481764016896152361495514773160561430714822150571427713934NANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:AdditionalPaidInCapital▇█▇▇▁▇▇▂▂▂▁▁655666856608653457566583652258255758581757545686NA5640NANANA5552NANANANANANANANANANANA4963NANANANANANANANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:CommonStock▁▁▁▁▂▆▆▇▇███598598600603607661667673680687688688NA688NANANA691NANANANANANANANANANANANANANANANANANANANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▂▁▁▁▁▅▇▇█▆█▇5879492049814318487911395144081424716608138941614515590NA16046NANANA16011NANANANANANANANANANANA16088NANANANANANANANANA
us-gaap:CommonStockValue ▁▁▁▁▁▄▅▅▆▆▆▆▆▆▆▆▆▆▆▆▆▆▆▇▇▇▇▇▇███████598598600603607661667673680687688688690688690690690691693693694694696699700698704704704716725725725724724724NANANA
us-gaap:AdditionalPaidInCapitalCommonStock ███▇▅█▇▅▅▅▅▄▄▄▄▄▄▄▄▃▃▃▃▂▂▂▂▂▂▂▂▂▁▁▁▁655666856608653457566583652258255758581757545686561756405648558755235552544153685279529252225120503450505042496949024963491948904858483847934736NANANA
us-gaap:RetainedEarningsAccumulatedDeficit ▂▁▁▁▁▅▆▆▇▆▇▇▇▇▇▇▇▇█▇▇▇█████▇▇▇█▇▇▇▆▆5879492049814318487911395144081424716608138941614515590158761604616601158241615516011168561611416706164821740617204176651699217811166081646216088170621573615906151251388813785NANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▁▂▃▃▃▃▃▂▃▃▄▄▄▃▅▅▅▄▄▅▄▅▇███▆▅▅▅▆▅▆▇██-6885-6523-5734-5600-5687-5729-5439-6108-5437-5718-4609-4774-5064-5274-4257-4371-4264-4580-4667-4403-4657-3991-2551-1935-1957-2002-3564-3948-4014-3797-3535-3934-3549-2505-2009-2188NANANA
us-gaap:TreasuryStockValue ▁▁▁▁▁▂▂▂▂▂▂▂▂▂▂▂▂▃▃▃▃▃▃▃▃▃▃▃▃█▃▃▃▃▃▃5560606262696969697575757580808080909090909191919193939393192949494959595NANANA
us-gaap:MinorityInterest ▂▂▂▂▂██▁▁▂▂▂▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁118927976841080107465607570687272261819191935261413111099978-7-2-11-20-3NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▃█▆▅▃▆█▆▃▇▇▇▃█▇▆▁▄▅▅▂▆▇▅▃382196315101051311144821211517436174318811651339211616591401-3268041104948-84134916911053272NANANA379NANANA852NANA1176NANA958
us-gaap:NetCashProvidedByUsedInInvestingActivities ▅▆▆▆▁▆▆█▆▇▅▅▅▅▅▅▆▆▆▆▆▅▅▆▆-1060-41-42361-7678-659-3983133-1701652-1758-2248-1429-1178-794-1020-145253-570182160-2178-1649-468388NANANA1355NANANA-652NANA-40NANA-52
us-gaap:NetCashProvidedByUsedInFinancingActivities ▆▅▄▅█▄▆▅▁▅▇▇▅▆▅▇▅▅▅▅▅█▅▅▅106-1113-1692-8851367-1639432-831-3866-5425001059-875274-597579-816-679-595-943-7011628-405-702-595NANANA-1730NANANA-2057NANA-713NANA-547
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▃█▆▅▃▆█▆▃▇▇▇▃█▇▆▁▄▅▅▂▆▇▅▃382196315101051311144821211517436174318811651339211616591401-3268041104948-84134916911053272NANANA379NANANA852NANA1176NANA958
us-gaap:NetIncomeLoss ▅▅▄▅█▄▄▃▄▁▄▄▃▄▄▄▃▄▄▄▄▃▄▄▄▄▄▄▅▄▅▄▄▄▄▄▅▅▄1456149512531327424111251149-2591217-16565551008-11077177874744047879960052942850073372772712031206154882713269231011123611971055130213481248
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:NoncontrollingInterest█▅▃▂▇▃▁▃▂▆▂26124-1224-540160NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▅▅▄▅█▄▄▃▄▁▄1456149512531327424111251149-2591217-1656555NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:DepreciationDepletionAndAmortization ▂▅▃▁▅▅███▇▆▇▆▅▇▆▆▅▅▆▅▅▅▅▅273340288247356345415425422411372395386344392373385343358368357339342348348NANANA381NANANA385NANA340NANA299
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet 1408NA247802714NA-2936621270NA1643-123-995NA18429-1429NA26227-913NA473-80-941NANANA1048NANANA698NANA-595NANA-815
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:NetCashProvidedByUsedInInvestingActivities ▅▆▆▆▁▆▆█▆▇▅▅▅▅▅▅▆▆▆▆▆▅▅▆▆-1060-41-42361-7678-659-3983133-1701652-1758-2248-1429-1178-794-1020-145253-570182160-2178-1649-468388NANANA1355NANANA-652NANA-40NANA-52
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:NetCashProvidedByUsedInFinancingActivities ▆▅▄▅█▄▆▅▁▅▇▇▅▆▅▇▅▅▅▅▅█▅▅▅106-1113-1692-8851367-1639432-831-3866-5425001059-875274-597579-816-679-595-943-7011628-405-702-595NANANA-1730NANANA-2057NANA-713NANA-547
us-gaap:ProceedsFromIssuanceOfLongTermDebt ▁▄▁▁█▁▅▁▁▁▁02108004448024770000NANA001206000227221820009920000NANANANANANANANANANA
us-gaap:RepaymentsOfLongTermDebt ▂█▁▁▃▁▁▂▃▁▁▁▃▁▁▁▁▁▁▇▁▁▁▁▄276226600600702018000006300000511950100311002NANANA0NANANA1500NANA54NANA0
 us-gaap:RepaymentsOfLongTermDebt us-gaap:BusinessAcquisition lly:DermiraInc.276NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:PaymentsOfDividends █▄▄▅▆▃▃▄▄▂▂▂▂▂▂▂▂▁▁▂▁▁▁▁▁671587587598637572572579587548547548547541537541538533526539527525525526524NANANA531NANANA544NANA543NANA539
us-gaap:PaymentsOfDividends █▄▄▅▆▃▃▄▄▂▂▂▂▂▂▂▂▁▁▂▁▁▁▁▁671587587598637572572579587548547548547541537541538533526539527525525526524NANANA531NANANA544NANA543NANA539
us-gaap:PaymentsForRepurchaseOfCommonStock ▂▂▂▁█▃▃▃▃▁▁▁▁▁▁▁▂▂▁▁▂▂▂▁▁50030060003500110010009501100990199060003002526112431030030014555NANANA1198NANANA0NANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
us-gaap:RepaymentsOfLongTermDebt ▂█▁▁▃▁▁▂▃▁▁▁▃▁▁▁▁▁▁▇▁▁▁▁▄276226600600702018000006300000511950100311002NANANA0NANANA1500NANA54NANA0
 us-gaap:RepaymentsOfLongTermDebt us-gaap:BusinessAcquisition lly:DermiraInc.276NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value598598600603607661667673680687688688690688690690690691693693694694696699700698704704704716725725725724724724724721718
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.51.51.61.61.61.51.51.61.51.51.61.71.81.81.81.92.01.91.91.91.91.92.02.02.02.02.12.12.22.12.12.32.32.22.22.22.32.32.6

Shares Issued

us-gaap:StatementEquityComponents

us-gaap:SharesIssued

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value95695896096597110571067107710891100110111011101110611111117114611581154
Percentage of SharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value0000000000000000200
Percentage of SharesIssued0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.10.1

Common Stock Shares Issued

Common Stock Shares Authorized

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value911918924984102610301049105610571056106010601063106510651067107410761075108410841091
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value908913920979102010301048105310551056105710571059106110611064106910711072108010801087
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value1.61.641.371.444.331.111.13-0.251.16-1.580.530.96-0.10.730.740.710.420.450.750.570.50.40.470.680.680.681.111.121.420.751.180.830.91
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value1.61.641.371.444.311.11.12-0.251.16-1.580.530.95-0.10.730.730.710.410.450.750.560.50.40.470.680.680.671.111.111.420.741.180.830.91
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Income Loss From Continuing Operations Per Basic Share

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1.61.641.371.440.571.111.07-0.221.11
Percentage of IncomeLossFromContinuingOperationsPerBasicShare100.0100.0100.0100.0100.0100.0100.0100.0100.0

Income Loss From Continuing Operations Per Diluted Share

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1.61.641.371.440.571.11.07-0.221.11
Percentage of IncomeLossFromContinuingOperationsPerDilutedShare100.0100.0100.0100.0100.0100.0100.0100.0100.0

Revenues

us-gaap:Revenues



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value585961145476563650926438606163555700616056585824522857605191540448655375495949784644512148754935468358085772592956025957544356005602614762525839565457485485
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService

lly:Alimta



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value560508577499520555499
Percentage of Revenues9.69.310.39.88.68.78.8
Percentage of Revenues9.69.310.39.88.68.78.8
Percentage of Revenues lly:Alimta100.0100.0100.0100.0100.0100.0100.0

lly:Basaglar



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value303307263290251232201201166
Percentage of Revenues5.25.04.85.24.93.63.33.22.9
Percentage of Revenues5.25.04.85.24.93.63.33.22.9
Percentage of Revenues lly:Basaglar100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cialis



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value193184200308467538495
Percentage of Revenues3.33.43.66.17.78.58.7
Percentage of Revenues3.33.43.66.17.78.58.7
Percentage of Revenues lly:Cialis100.0100.0100.0100.0100.0100.0100.0

lly:CollaborationandOtherRevenue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value456579494468399415397455357330334294
Percentage of Revenues7.89.59.08.37.96.56.67.26.35.45.95.1
Percentage of Revenues7.89.59.08.37.96.56.67.26.35.45.95.1
Percentage of Revenues lly:CollaborationandOtherRevenue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cymbalta



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value210178187164172181169
Percentage of Revenues3.63.33.33.22.82.93.0
Percentage of Revenues3.63.33.33.22.82.93.0
Percentage of Revenues lly:Cymbalta100.0100.0100.0100.0100.0100.0100.0

lly:Cyramza



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value239240241198198218183
Percentage of Revenues4.14.44.33.93.33.43.2
Percentage of Revenues4.14.44.33.93.33.43.2
Percentage of Revenues lly:Cyramza100.0100.0100.0100.0100.0100.0100.0

lly:Diabetes



Period End2020-03-312019-03-31
Value29682553
Percentage of Revenues50.750.1
Percentage of Revenues50.750.1
Percentage of Revenues lly:Diabetes100.0100.0

lly:Emgality



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value74473414000
Percentage of Revenues1.30.90.60.30.00.00.0
Percentage of Revenues1.30.90.60.30.00.00.0
Percentage of Revenues lly:Emgality100.0100.0100.0100.00.00.00.0

lly:Erbitux



Period End2020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value13012815911815915916614916817685134889692939087919486110113971001049510392
Percentage of Revenues2.22.32.82.32.52.62.62.63.53.31.72.71.91.91.91.91.91.51.51.71.62.02.01.61.61.81.71.81.7
Percentage of Revenues2.22.32.82.32.52.62.62.63.53.31.72.71.91.91.91.91.91.51.51.71.62.02.01.61.61.81.71.81.7
Percentage of Revenues lly:Erbitux100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Forteo



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value272370360312390434313
Percentage of Revenues4.66.86.46.16.46.85.5
Percentage of Revenues4.66.86.46.16.46.85.5
Percentage of Revenues lly:Forteo100.0100.0100.0100.0100.0100.0100.0

lly:Humalog



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value695648677730664769791
Percentage of Revenues11.911.812.014.411.012.113.9
Percentage of Revenues11.911.812.014.411.012.113.9
Percentage of Revenues lly:Humalog100.0100.0100.0100.0100.0100.0100.0

lly:Humulin



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value315321322297322346325
Percentage of Revenues5.45.95.75.85.35.45.7
Percentage of Revenues5.45.95.75.85.35.45.7
Percentage of Revenues lly:Humulin100.0100.0100.0100.0100.0100.0100.0

lly:Immunology



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value585454456334319264178
Percentage of Revenues10.08.38.16.65.34.23.1
Percentage of Revenues10.08.38.16.65.34.23.1
Percentage of Revenues lly:Immunology100.0100.0100.0100.0100.0100.0100.0

lly:Jardiance



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value267268240231203193166147151
Percentage of Revenues4.64.44.44.14.03.02.82.32.6
Percentage of Revenues4.64.44.44.14.03.02.82.32.6
Percentage of Revenues lly:Jardiance100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Neuroscience



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value463426452393427471472
Percentage of Revenues7.97.88.07.77.07.48.3
Percentage of Revenues7.97.88.07.77.07.48.3
Percentage of Revenues lly:Neuroscience100.0100.0100.0100.0100.0100.0100.0

lly:Olumiant



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value13912711410282705544
Percentage of Revenues2.42.12.11.81.61.10.90.7
Percentage of Revenues2.42.12.11.81.61.10.90.7
Percentage of Revenues lly:Olumiant100.0100.0100.0100.0100.0100.0100.0100.0

lly:Oncology



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value120111471197101210641110956
Percentage of Revenues20.521.021.219.917.617.516.8
Percentage of Revenues20.521.021.219.917.617.516.8
Percentage of Revenues lly:Oncology100.0100.0100.0100.0100.0100.0100.0

lly:OtherDiabetes



Period End2020-03-312019-03-31
Value6357
Percentage of Revenues1.11.1
Percentage of Revenues1.11.1
Percentage of Revenues lly:OtherDiabetes100.0100.0

lly:OtherImmunology



Period End2020-03-312019-03-312018-03-31
Value28232
Percentage of Revenues0.01.60.6
Percentage of Revenues0.01.60.6
Percentage of Revenues lly:OtherImmunology100.0100.0100.0

lly:OtherNeuroscience



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value80424441464649
Percentage of Revenues1.40.80.80.80.80.70.9
Percentage of Revenues1.40.80.80.80.80.70.9
Percentage of Revenues lly:OtherNeuroscience100.0100.0100.0100.0100.0100.0100.0

lly:OtherOncology



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value83113848710111194
Percentage of Revenues1.42.11.51.71.71.81.7
Percentage of Revenues1.42.11.51.71.71.81.7
Percentage of Revenues lly:OtherOncology100.0100.0100.0100.0100.0100.0100.0

lly:OtherProduct



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value174119123113191245161
Percentage of Revenues3.02.22.22.23.23.92.8
Percentage of Revenues3.02.22.22.23.23.92.8
Percentage of Revenues lly:OtherProduct100.0100.0100.0100.0100.0100.0100.0

lly:OtherProductTotal



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value640303323421658784657
Percentage of Revenues10.95.55.78.310.912.311.5
Percentage of Revenues10.95.55.78.310.912.311.5
Percentage of Revenues lly:OtherProductTotal100.0100.0100.0100.0100.0100.0100.0

lly:Taltz



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value443340353252263220146
Percentage of Revenues7.66.26.35.04.43.52.6
Percentage of Revenues7.66.26.35.04.43.52.6
Percentage of Revenues lly:Taltz100.0100.0100.0100.0100.0100.0100.0

lly:TrajentaBI



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312015-03-312014-03-31
Value931491551531311561351411418276
Percentage of Revenues1.62.42.82.72.62.42.22.22.51.81.6
Percentage of Revenues1.62.42.82.72.62.42.22.22.51.81.6
Percentage of Revenues lly:TrajentaBI100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:TrulicityMember



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value122910111028879816779678
Percentage of Revenues21.018.518.217.313.512.311.9
Percentage of Revenues21.018.518.217.313.512.311.9
Percentage of Revenues lly:TrulicityMember100.0100.0100.0100.0100.0100.0100.0

lly:Verzenio



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value188157133109845729
Percentage of Revenues3.22.92.42.11.40.90.5
Percentage of Revenues3.22.92.42.11.40.90.5
Percentage of Revenues lly:Verzenio100.0100.0100.0100.0100.0100.0100.0

lly:Zyprexa



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value98105104107109128122
Percentage of Revenues1.71.91.92.11.82.02.2
Percentage of Revenues1.71.91.92.11.82.02.2
Percentage of Revenues lly:Zyprexa100.0100.0100.0100.0100.0100.0100.0

us-gaap:Product



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value540355344982516846926023566458994605582953235529
Percentage of Revenues92.290.591.091.792.193.593.492.880.894.694.194.9
Percentage of Revenues92.290.591.091.792.193.593.492.880.894.694.194.9
Percentage of Revenues us-gaap:Product100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Royalty



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value35138675935447613350403635
Percentage of Revenues0.62.31.21.10.70.71.32.10.90.70.60.6
Percentage of Revenues0.62.31.21.10.70.71.32.10.90.70.60.6
Percentage of Revenues us-gaap:Royalty100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService, us-gaap:StatementGeographical

lly:Alimta, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value324313282341281315288281245
Percentage of Revenues5.55.15.26.15.54.94.84.44.3
Percentage of Revenues5.55.15.26.15.54.94.84.44.3
Percentage of Revenues lly:Alimta country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Alimta, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value235217225236217241232274
Percentage of Revenues4.03.64.14.24.33.73.84.3
Percentage of Revenues4.03.64.14.24.33.73.84.3
Percentage of Revenues lly:Alimta us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Basaglar, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value230243202232198182157156126
Percentage of Revenues3.94.03.74.13.92.82.62.52.2
Percentage of Revenues3.94.03.74.13.92.82.62.52.2
Percentage of Revenues lly:Basaglar country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Basaglar, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value7363605853504345
Percentage of Revenues1.31.01.11.01.00.80.70.7
Percentage of Revenues1.31.01.11.01.00.80.70.7
Percentage of Revenues lly:Basaglar us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cialis, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value26223035143174295345313
Percentage of Revenues0.40.40.60.62.82.74.95.45.5
Percentage of Revenues0.40.40.60.62.82.74.95.45.5
Percentage of Revenues lly:Cialis country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cialis, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value167175153165164176171193
Percentage of Revenues2.82.92.82.93.22.72.83.0
Percentage of Revenues2.82.92.82.93.22.72.83.0
Percentage of Revenues lly:Cialis us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cymbalta, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value111010181015141212
Percentage of Revenues0.20.20.20.30.20.20.20.20.2
Percentage of Revenues0.20.20.20.30.20.20.20.20.2
Percentage of Revenues lly:Cymbalta country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cymbalta, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value198184168169153169157169
Percentage of Revenues3.43.03.13.03.02.62.62.7
Percentage of Revenues3.43.03.13.03.02.62.62.7
Percentage of Revenues lly:Cymbalta us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cyramza, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value898782897580677568
Percentage of Revenues1.51.41.51.61.51.31.11.21.2
Percentage of Revenues1.51.41.51.61.51.31.11.21.2
Percentage of Revenues lly:Cyramza country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Cyramza, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value149157157152123139131143
Percentage of Revenues2.62.62.92.72.42.22.22.3
Percentage of Revenues2.62.62.92.72.42.22.22.3
Percentage of Revenues lly:Cyramza us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Diabetes, country:US



Period End2020-03-312019-03-31
Value19911719
Percentage of Revenues34.033.8
Percentage of Revenues34.033.8
Percentage of Revenues lly:Diabetes country:US100.0100.0

lly:Diabetes, us-gaap:NonUs



Period End2020-03-312019-03-31
Value977833
Percentage of Revenues16.716.4
Percentage of Revenues16.716.4
Percentage of Revenues lly:Diabetes us-gaap:NonUs100.0100.0

lly:Emgality, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value67634533124000
Percentage of Revenues1.11.00.80.60.20.10.00.00.0
Percentage of Revenues1.11.00.80.60.20.10.00.00.0
Percentage of Revenues lly:Emgality country:US100.0100.0100.0100.0100.0100.00.00.00.0

lly:Emgality, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value63102000
Percentage of Revenues0.10.10.00.00.00.00.00.0
Percentage of Revenues0.10.10.00.00.00.00.00.0
Percentage of Revenues lly:Emgality us-gaap:NonUs100.0100.0100.0100.0100.00.00.00.0

lly:Erbitux, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value117123113136113137132140121
Percentage of Revenues2.02.02.12.42.22.12.22.22.1
Percentage of Revenues2.02.02.12.42.22.12.22.22.1
Percentage of Revenues lly:Erbitux country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Erbitux, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value131314225222626
Percentage of Revenues0.20.20.30.40.10.30.40.4
Percentage of Revenues0.20.20.30.40.10.30.40.4
Percentage of Revenues lly:Erbitux us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Forteo, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value122171175172125228182225122
Percentage of Revenues2.12.83.23.12.53.53.03.52.1
Percentage of Revenues2.12.83.23.12.53.53.03.52.1
Percentage of Revenues lly:Forteo country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Forteo, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value149188195188187208208209
Percentage of Revenues2.63.13.63.33.73.23.43.3
Percentage of Revenues2.63.13.63.33.73.23.43.3
Percentage of Revenues lly:Forteo us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Humalog, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value398468356396448453365464504
Percentage of Revenues6.87.76.57.08.87.06.07.38.8
Percentage of Revenues6.87.76.57.08.87.06.07.38.8
Percentage of Revenues lly:Humalog country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Humalog, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value297294292281282316299305
Percentage of Revenues5.14.85.35.05.54.94.94.8
Percentage of Revenues5.14.85.35.05.54.94.94.8
Percentage of Revenues lly:Humalog us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Humulin, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value214240218220201232216238221
Percentage of Revenues3.73.94.03.94.03.63.63.83.9
Percentage of Revenues3.73.94.03.94.03.63.63.83.9
Percentage of Revenues lly:Humulin country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Humulin, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value10110710310296104105107
Percentage of Revenues1.71.81.91.81.91.61.71.7
Percentage of Revenues1.71.81.91.81.91.61.71.7
Percentage of Revenues lly:Humulin us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Immunology, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value341330262278187247211175111
Percentage of Revenues5.85.44.84.93.73.83.52.82.0
Percentage of Revenues5.85.44.84.93.73.83.52.82.0
Percentage of Revenues lly:Immunology country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Immunology, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value24421719117714712910889
Percentage of Revenues4.23.63.53.12.92.01.81.4
Percentage of Revenues4.23.63.53.12.92.01.81.4
Percentage of Revenues lly:Immunology us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Jardiance, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1441571401421251151048595
Percentage of Revenues2.52.62.62.52.51.81.71.31.7
Percentage of Revenues2.52.62.62.52.51.81.71.31.7
Percentage of Revenues lly:Jardiance country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Jardiance, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value1221101008978776261
Percentage of Revenues2.11.81.81.61.51.21.01.0
Percentage of Revenues2.11.81.81.61.51.21.01.0
Percentage of Revenues lly:Jardiance us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Neuroscience, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value110106941045163556591
Percentage of Revenues1.91.71.71.91.01.00.91.01.6
Percentage of Revenues1.91.71.71.91.01.00.91.01.6
Percentage of Revenues lly:Neuroscience country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Neuroscience, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value353344332348342385371405
Percentage of Revenues6.05.66.16.26.76.06.16.4
Percentage of Revenues6.05.66.16.26.76.06.16.4
Percentage of Revenues lly:Neuroscience us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Olumiant, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value111312106401
Percentage of Revenues0.20.20.20.20.10.10.00.0
Percentage of Revenues0.20.20.20.20.10.10.00.0
Percentage of Revenues lly:Olumiant country:US100.0100.0100.0100.0100.0100.0100.0100.0

lly:Olumiant, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value1281141029175655442
Percentage of Revenues2.21.91.91.61.51.00.90.7
Percentage of Revenues2.21.91.91.61.51.00.90.7
Percentage of Revenues lly:Olumiant us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Oncology, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value657684640689593662619611510
Percentage of Revenues11.211.211.712.211.710.310.29.69.0
Percentage of Revenues11.211.211.712.211.710.310.29.69.0
Percentage of Revenues lly:Oncology country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Oncology, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value543572507507418467444499
Percentage of Revenues9.39.49.39.08.27.37.37.9
Percentage of Revenues9.39.49.39.08.27.37.37.9
Percentage of Revenues lly:Oncology us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherDiabetes, country:US



Period End2020-03-312019-03-31
Value4533
Percentage of Revenues0.80.7
Percentage of Revenues0.80.7
Percentage of Revenues lly:OtherDiabetes country:US100.0100.0

lly:OtherDiabetes, us-gaap:NonUs



Period End2020-03-312019-03-31
Value1824
Percentage of Revenues0.30.5
Percentage of Revenues0.30.5
Percentage of Revenues lly:OtherDiabetes us-gaap:NonUs100.0100.0

lly:OtherImmunology, country:US



Period End2020-03-312019-03-312018-03-31
Value260
Percentage of Revenues0.00.10.0
Percentage of Revenues0.00.10.0
Percentage of Revenues lly:OtherImmunology country:US100.0100.00.0

lly:OtherNeuroscience, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value202118221720232423
Percentage of Revenues0.30.40.30.40.30.30.40.40.4
Percentage of Revenues0.30.40.30.40.30.30.40.40.4
Percentage of Revenues lly:OtherNeuroscience country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherNeuroscience, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value6023242288222322
Percentage of Revenues1.00.40.40.41.70.30.40.4
Percentage of Revenues1.00.40.40.41.70.30.40.4
Percentage of Revenues lly:OtherNeuroscience us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherOncology, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-22736163051475645
Percentage of Revenues-0.00.50.70.30.60.80.80.90.8
Percentage of Revenues-0.00.50.70.30.60.80.80.90.8
Percentage of Revenues lly:OtherOncology country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherOncology, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value86137766857585454
Percentage of Revenues1.52.21.41.21.10.90.90.9
Percentage of Revenues1.52.21.41.21.10.90.90.9
Percentage of Revenues lly:OtherOncology us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherProduct, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value7927444241379114353
Percentage of Revenues1.40.50.80.80.80.61.52.30.9
Percentage of Revenues1.40.50.80.80.80.61.52.30.9
Percentage of Revenues lly:OtherProduct country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherProduct, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value9510074801078299102
Percentage of Revenues1.61.61.41.42.11.31.61.6
Percentage of Revenues1.61.61.41.42.11.31.61.6
Percentage of Revenues lly:OtherProduct us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherProductTotal, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value228507577184211387489367
Percentage of Revenues3.90.81.41.43.63.36.47.76.4
Percentage of Revenues3.90.81.41.43.63.36.47.76.4
Percentage of Revenues lly:OtherProductTotal country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherProductTotal, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value412275227245459258271295
Percentage of Revenues7.04.54.24.49.04.04.54.6
Percentage of Revenues7.04.54.24.49.04.04.54.6
Percentage of Revenues lly:OtherProductTotal us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Taltz, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value327317250268180243210173111
Percentage of Revenues5.65.24.64.83.63.83.52.72.0
Percentage of Revenues5.65.24.64.83.63.83.52.72.0
Percentage of Revenues lly:Taltz country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Taltz, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value116102898571635346
Percentage of Revenues2.01.71.61.51.41.00.90.7
Percentage of Revenues2.01.71.61.51.41.00.90.7
Percentage of Revenues lly:Taltz us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:TrajentaBI, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value285260644762505654
Percentage of Revenues0.50.91.11.10.91.00.80.90.9
Percentage of Revenues0.50.91.11.10.91.00.80.90.9
Percentage of Revenues lly:TrajentaBI country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:TrajentaBI, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value6496958984938584
Percentage of Revenues1.11.61.71.61.71.41.41.3
Percentage of Revenues1.11.61.71.61.71.41.41.3
Percentage of Revenues lly:TrajentaBI us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:TrulicityMember, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value929942755792665729645612528
Percentage of Revenues15.915.413.814.113.111.310.79.69.3
Percentage of Revenues15.915.413.814.113.111.310.79.69.3
Percentage of Revenues lly:TrulicityMember country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:TrulicityMember, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value299266256236214195170167
Percentage of Revenues5.14.44.74.24.23.02.82.6
Percentage of Revenues5.14.44.74.24.23.02.82.6
Percentage of Revenues lly:TrulicityMember us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

lly:Verzenio, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1291311241059376845729
Percentage of Revenues2.22.12.31.91.81.21.40.90.5
Percentage of Revenues2.22.12.31.91.81.21.40.90.5
Percentage of Revenues lly:Verzenio country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Verzenio, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value5847322815600
Percentage of Revenues1.00.80.60.50.30.10.00.0
Percentage of Revenues1.00.80.60.50.30.10.00.0
Percentage of Revenues lly:Verzenio us-gaap:NonUs100.0100.0100.0100.0100.0100.00.00.0

lly:Zyprexa, country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1111119987118
Percentage of Revenues0.20.20.20.20.20.10.10.20.2
Percentage of Revenues0.20.20.20.20.20.10.10.20.2
Percentage of Revenues lly:Zyprexa country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:Zyprexa, us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value8790949597102102116
Percentage of Revenues1.51.51.71.71.91.61.71.8
Percentage of Revenues1.51.51.71.71.91.61.71.8
Percentage of Revenues lly:Zyprexa us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementGeographical

country:CN



Period End2020-03-312019-03-31
Value267211
Percentage of Revenues4.64.1
Percentage of Revenues4.64.1
Percentage of Revenues country:CN100.0100.0

country:JP



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value592709641653543664608664555652616627522
Percentage of Revenues10.111.611.711.610.710.310.010.59.810.610.910.810.0
Percentage of Revenues10.111.611.711.610.710.310.010.59.810.610.910.810.0
Percentage of Revenues country:JP100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value3328351930603252289036643446360231543423310433232933
Percentage of Revenues56.857.655.957.756.856.956.956.755.355.654.957.156.1
Percentage of Revenues56.857.655.957.756.856.956.956.755.355.654.957.156.1
Percentage of Revenues country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:OtherForeignCountries



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value61087285180275710219899989541019920909875
Percentage of Revenues10.414.315.514.214.915.916.315.716.716.516.315.616.7
Percentage of Revenues10.414.315.514.214.915.916.315.716.716.516.315.616.7
Percentage of Revenues lly:OtherForeignCountries100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

srt:Europe



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1061101392392890010881017109086410651017963
Percentage of Revenues18.116.616.916.517.716.916.817.215.217.318.016.5
Percentage of Revenues18.116.616.916.517.716.916.817.215.217.318.016.5
Percentage of Revenues srt:Europe100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value25312594241623842201235422362342
Percentage of Revenues43.242.444.142.343.236.636.936.9
Percentage of Revenues43.242.444.142.343.236.636.936.9
Percentage of Revenues us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0

Sales Revenue Goods Net

Cost Of Goods And Services Sold

us-gaap:CostOfGoodsAndServicesSold



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value1215128211751124113815931562170215711644158615711347
Percentage of CostOfGoodsAndServicesSold100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues20.721.021.520.022.424.825.826.827.626.728.027.025.8

Cost Of Goods Sold

Operating Expenses

Research And Development Expense

us-gaap:ResearchAndDevelopmentExpense



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value1392158113801402123014531343133311761473131912501238145012361335122114441143116910391185124311951109137713301348134213201151128012601124121911871039
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues23.825.925.224.924.222.622.221.020.623.923.321.523.725.223.824.725.126.923.123.522.423.225.524.223.723.922.424.124.723.620.620.820.219.221.620.718.9

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value1549169814121586151718611616165315001780155517071544179015651622147317981575163515231799167216631484165218671652175719311847191720431785169417551614
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues26.427.825.828.129.828.926.726.026.328.927.529.329.531.130.230.030.333.531.832.832.835.134.333.731.728.631.529.532.334.533.031.232.730.630.030.529.4

Interest Expense

us-gaap:InterestExpense



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value9295107110867869636162615346514743434439364037383537394040474345454545474747
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues1.61.62.02.01.71.21.11.01.11.01.10.90.90.90.90.80.90.80.80.70.90.70.80.70.80.70.70.70.90.80.80.70.70.80.80.80.9

Other Nonoperating Income Expense

us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value12223613986-47-4152665212293545407465104591121501025559-232250220-26-60-3019918111
Percentage of OtherNonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues2.13.90.20.21.7-0.7-0.70.10.51.10.10.20.60.60.90.81.51.22.11.22.42.92.11.11.3-0.40.40.90.4-0.0-0.5-1.0-0.50.30.20.32.0

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, lly:AccumulatedNetGainLossfromCashFlowHedgesandForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-312016-09-30
Value-360-2-2-4-35-230-321022
Percentage of OtherNonoperatingIncomeExpense-2.525.4-21.5-31.2-5.575.46.6578.8-12.33.5362.17.15.5
Percentage of Revenues-0.11.0-0.1-0.1-0.1-0.6-0.00.5-0.10.00.20.00.0
Percentage of Revenues us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome lly:AccumulatedNetGainLossfromCashFlowHedgesandForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-111-71-71-73-70-75-79-93-92
Percentage of OtherNonoperatingIncomeExpense-91.1-30.4-548.5-790.3-81.5158.5193.9-1794.2-344.4
Percentage of Revenues-1.9-1.2-1.3-1.3-1.4-1.2-1.3-1.5-1.6
Percentage of Revenues us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.0

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value131414141418181919
Percentage of OtherNonoperatingIncomeExpense11.26.0109.2152.716.5-37.9-44.4367.372.0
Percentage of Revenues0.20.20.30.30.30.30.30.30.3
Percentage of Revenues us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.0

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-30
Value1679166314051465731938141141441284591126061892970944566444104767961751365594089015131514195118741185133515021531
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues28.727.225.726.014.414.623.30.125.34.610.521.61.215.518.717.511.78.321.113.713.310.013.419.119.026.225.534.834.421.223.824.424.5

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-98-57-57-59-55-57-61-74-73
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-5.8-3.5-4.1-4.0-7.6-6.1-4.3-1545.8-5.1
Percentage of Revenues-1.7-0.9-1.0-1.1-1.1-0.9-1.0-1.2-1.3
Percentage of Revenues us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.0

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value145614951253132756111211093-2311167
Percentage of IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues24.924.522.923.511.017.418.0-3.620.5

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-8017-47-49-49-47-51-28-61
Percentage of IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest-5.51.1-3.8-3.8-8.8-4.3-4.712.3-5.2
Percentage of Revenues-1.40.3-0.9-0.9-1.0-0.7-0.8-0.4-1.1
Percentage of Revenues us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.0

Nonoperating Income Expense

us-gaap:NonoperatingIncomeExpense



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value89262-24-3286-15-15386755-13-315152721-1494486-123921379353569-3111529-52788-16-46-83-57-11-21-1874
Percentage of NonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues1.54.3-0.5-0.61.7-0.2-0.30.61.20.9-0.2-0.10.30.30.50.4-3.10.81.7-2.52.02.71.91.11.20.2-0.50.29.4-0.914.5-0.3-0.8-1.4-0.9-0.2-0.4-0.31.4

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value223167151138170-186261264223194136252172120192196126-33248788885154206162310308403548262324266334218368387459
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues3.82.72.82.53.3-2.94.34.23.931.50.64.33.32.13.73.62.6-0.65.01.61.91.73.24.23.55.45.27.210.14.75.84.35.33.76.56.78.4

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-20-12-12-12-11-12-12-15-15
Percentage of IncomeTaxExpenseBenefit-9.2-7.7-7.9-8.9-6.66.4-4.9-5.9-6.8
Percentage of Revenues-0.4-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.3
Percentage of Revenues us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.0

Income Taxes Paid Net

Profit Loss

us-gaap:StatementEquityComponents

us-gaap:ProfitLoss

us-gaap:NoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value26124-1224-540160
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues0.40.20.1-0.00.40.1-0.10.10.00.30.0
Percentage of Revenues us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value1456149512531327424111251149-2591217-1656555
Percentage of ProfitLoss5559.212464.227258.7-120654.519106.326162.8-22105.8-6188.1304350.0-10227.8185200.0
Percentage of Revenues24.924.522.923.583.317.519.0-4.121.4-26.99.8
Percentage of Revenues us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.0

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value10941119141442941809-9311603723129287-196891641756564535855-136-1011-11575577315871271133017245381320740137615372080818943
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues18.720.425.184.329.9-14.728.112.822.21.7-3.417.211.915.510.510.817.2-2.9-19.8-2.415.316.527.521.423.831.79.623.612.022.026.336.814.217.2

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

us-gaap:StatementEquityComponents

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-30
Value-362-1348741660-671386165
Percentage of ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-6.2-2.41.50.810.9-10.66.82.9
Percentage of Revenues us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.0

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value1456149512531327424111251149-2591217-16565551008-11077177874744047879960052942850073372772712031206154882713269231011123611971055130213481248
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues24.924.522.923.583.317.519.0-4.121.4-26.99.817.3-2.113.415.013.89.08.916.112.111.48.410.314.915.512.520.820.327.613.924.416.518.020.119.118.123.023.522.8

Net Income Loss Available To Common Stockholders Basic

Assets

us-gaap:Assets



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value411023928637893386663800643908446254235944355449814301040946376243880537590364753469135568363043603635653371783464835018347563524833965332263230034398343213181232238336593304232779316953100127460
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value411023928637893386663800643908446254235944355449814301040946376243880537590364753469135568363043603635653371783464835018347563524833965332263230034398343213181232238336593304232779316953100127460
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-312010-12-31
Value3078260633822780248098281307611555145271159214890141001403114007155891463715009145711522114670149191537317669179831833817631147651354112420
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.56.68.97.26.522.429.327.332.825.834.634.437.336.141.540.143.341.041.940.741.841.451.051.452.850.042.940.240.1

Assets Current

us-gaap:AssetsCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value139941370912661134541259720549206851833216261192021742815746129761510113385129771171412573125671234611742121791211013156130391310413202126391232613038140381230712602142481457214950153541484012486
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets34.034.933.434.833.146.846.443.336.742.740.538.534.538.935.635.633.835.334.634.332.932.835.037.637.537.238.938.038.237.940.938.739.142.344.145.648.447.945.5

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue



Period End2020-03-312019-12-312019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312008-12-312007-12-31
Value1699233722902036799889606817308465363724306926164582348932382307366632383315306438713165376538883830436837863936401853194345412259226597611365065993590851634725446254963220
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.15.95.95.418.220.116.17.014.58.77.57.011.89.38.96.710.38.99.28.610.49.110.811.210.912.911.412.211.715.513.712.817.620.018.720.519.30.00.00.016.30.00.0

Short Term Investments

us-gaap:ShortTermInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value7810189771008876921705149732182364888145673769668778510809151075955164413601324156710109247951665158091580297418621620673334
Percentage of ShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.30.20.20.30.20.20.23.83.37.55.82.43.82.01.92.02.23.02.53.02.64.73.93.84.43.02.82.54.84.62.92.52.90.60.70.72.40.1

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value510645474441461242005246485948234495454644014349401740293848394736223513340133483142323430533187300234343445357934393336326831813402359735333833369434933343
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets12.411.611.711.911.111.910.911.410.110.110.210.610.710.410.210.810.49.99.49.38.88.78.89.18.69.710.110.810.69.79.510.010.610.710.711.711.711.312.2

Inventory Net

us-gaap:InventoryNet



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value310231903101318130554111411841554631445844064346403535613881375937403445341732882980274028443190296929282974272525762643255323202424229925132870276725172849
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.58.18.28.28.09.49.29.810.49.910.210.610.79.210.310.310.89.79.49.18.47.48.29.18.58.38.88.28.07.77.47.37.56.87.68.88.78.110.4

Inventory Finished Goods

Inventory L I F O Reserve

Land

Machinery And Equipment Gross

Noncurrent Assets

Property Plant And Equipment Gross

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value914191619055895687929544967195669539926491328950871185258985886187508607853683818262806580388012780876717575740172647157730570857011683368066716657265456902
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets22.223.323.923.223.121.721.722.621.520.621.221.923.222.023.924.325.224.223.523.323.221.723.222.922.521.822.322.322.520.821.322.321.720.320.620.520.721.125.1

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value789778727801784777808919881487708958882685988582842582528251806680338053807580227950796380438100797079757767763676237760763876197754776078127953796779408197
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets19.220.020.620.320.520.319.820.720.219.620.021.022.421.322.022.123.222.622.222.322.321.423.223.122.922.622.923.023.622.622.324.024.123.123.624.325.125.629.9

Long Term Investments

us-gaap:LongTermInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value214819621825185221112020200520595375567861485723529752075027444937643646410240994576456874056649720476247220656156366313522445474521402932192943189817791155
Percentage of LongTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.25.04.84.85.64.64.54.912.112.614.314.014.113.413.412.210.910.311.311.412.812.321.419.020.721.621.319.717.418.415.214.314.012.09.79.06.05.74.2

us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value2148196218251852211120202005205953755678
Percentage of LongTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.25.04.84.85.64.64.54.912.112.6
Percentage of Assets us-gaap:CarryingReportedAmountFairValueDisclosure0.00.00.00.00.00.00.00.00.00.0

Goodwill

us-gaap:Goodwill



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Value377936793772382038554347435843334412437043654290418839724007402640454039405440243946175815161501143414231175
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets9.29.410.09.910.19.99.810.29.99.710.210.511.110.210.711.011.711.411.211.211.14.74.34.44.34.64.3

us-gaap:BusinessAcquisition

lly:DermiraInc.



Period End2020-02-29
Value99
Percentage of Goodwill0.0
Percentage of Assets0.0
Percentage of Assets lly:DermiraInc.0.0

Intangible Assets Net Excluding Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-31
Value77666618668965866641352136193772392040294271454247164357463848064889503446154842494728842814
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets18.916.817.717.017.58.08.18.98.89.09.911.112.511.212.313.214.114.212.713.413.97.88.0

Finite Lived Intangible Assets Net

Deferred Tax Assets Liabilities Net

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value304428712194205219631892200917761746287421972060202019132279214922442220288927012489241723382441233922121320188020952534238721952093249322151976174316221921
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.47.35.85.35.24.34.54.23.96.45.15.05.44.96.15.96.56.28.07.57.06.56.77.06.76.33.95.76.57.47.06.96.57.46.76.05.55.27.0

Liabilities Current

us-gaap:LiabilitiesCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value126101177510828118551123611888108261305511547145351266611294104481098682728401734082298303823283421120775747417663189168076840875938389696066096553893082198620765171016568
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets30.730.028.630.729.627.124.330.826.032.329.427.627.828.322.023.021.223.122.922.823.430.121.921.219.125.323.825.323.524.420.320.820.326.524.926.324.122.923.9

Debt Current

us-gaap:DebtCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value32481499156320682354113110023049230437063538244426091937641645648691080526883131091012101911
Percentage of DebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.93.84.15.36.22.62.27.25.28.28.26.06.95.01.71.81.90.00.00.02.37.20.90.00.02.93.00.0

Long Term Debt Current

Accounts Payable Current

us-gaap:AccountsPayableCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1207140511141198116814121281131612671410120012571220134911611207115113381179115311791128102311241149111912471141974118813281201124611251154118711831072968
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.93.62.93.13.13.22.93.12.93.12.83.13.23.53.13.33.33.83.23.23.33.03.03.23.33.23.73.43.03.53.93.83.93.33.53.63.73.53.5

Taxes Payable Current

us-gaap:TaxesPayableCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312013-12-312012-12-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value6671601802224914044094646935324142361221191838811435870093254143261144183315457346
Percentage of TaxesPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.60.40.50.61.30.90.91.11.61.21.00.60.30.30.50.20.31.01.90.30.70.40.80.40.61.01.51.3

Accrued Income Taxes Current

Other Liabilities Current

us-gaap:OtherLiabilitiesCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value221721891988218922542213214621902346283223602112223222202001220022762460209926252516247220602036233023282110229722742738281625902754290327202786260026512683
Percentage of OtherLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.45.65.25.75.95.04.85.25.36.35.55.25.95.75.36.06.66.95.87.37.16.75.95.86.76.66.26.97.08.08.28.18.58.68.28.58.28.69.8

Dividends Payable Current

us-gaap:DividendsPayableCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value0671059306500578059005470548053705390529053005240523052705410543054205420540538
Percentage of DividendsPayableCurrent0.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.00.0100.0100.0
Percentage of Assets0.01.70.01.50.01.50.01.40.01.30.01.30.01.40.01.50.01.50.01.50.01.40.01.50.01.50.01.60.01.60.01.70.01.60.01.70.01.72.0

Liabilities Noncurrent

us-gaap:LiabilitiesNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value252952481123602239532420521111196471768318220187771538315482130721373813701134181232112749127601309912364105829391960697768691899395819750112351130310895108611119397659881101091148711367
Percentage of LiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets61.563.262.361.963.748.144.041.741.141.735.837.834.735.436.536.835.535.835.136.334.728.527.127.428.124.726.528.830.232.732.934.233.733.329.630.131.937.141.4

Long Term Debt

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:LongTermDebt

us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value151191515015219148331423812461125421006310583115291144811318876094191006499268172
Percentage of LongTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets36.838.640.238.437.528.428.123.823.925.626.627.623.324.326.827.223.0
Percentage of Assets us-gaap:FairValueInputsLevel2 us-gaap:EstimateOfFairValueFairValueDisclosure0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value13987138231366713727136151227212277977110203109501093810887844790059348933179785340
Percentage of LongTermDebt92.591.289.892.595.698.597.997.196.495.095.596.296.495.692.994.097.60.0
Percentage of Assets34.035.236.135.535.827.927.523.123.024.325.426.622.523.224.925.622.414.4
Percentage of Assets us-gaap:CarryingReportedAmountFairValueDisclosure0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value1511915150152191483314238124611254210063105831152911448113188760941910064992681725722
Percentage of LongTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets36.838.640.238.437.528.428.123.823.925.626.627.623.324.326.827.223.015.4
Percentage of Assets us-gaap:EstimateOfFairValueFairValueDisclosure0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:LongtermDebtType

lly:ForeignCurrencyDenominatedDebt



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302015-12-31
Value5430549032803380333034003450340038103700367036103420334035502270
Percentage of LongTermDebt35.936.221.622.823.427.327.533.836.032.132.131.939.035.535.327.8
Percentage of Assets13.214.08.78.78.87.77.78.08.68.28.58.89.18.69.46.4
Percentage of Assets lly:ForeignCurrencyDenominatedDebt0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Long Term Debt Noncurrent

us-gaap:LongTermDebtNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value1398213817136621371713610116391167491709393994099269867763783678707868574777972806979887415536752925301525542004263429044315519551055005403546454515200513267706634
Percentage of LongTermDebtNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets34.035.236.135.535.826.526.221.621.222.123.124.120.321.623.223.821.622.422.222.220.814.415.315.115.111.912.612.913.716.016.117.316.816.216.515.916.221.824.2

Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent

us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value363236982414272327572911268434203505351324582465245524532077202021062160235826292520256215241528155315492607262126603012270227142766306818051848186618872334
Percentage of PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.89.46.47.07.36.66.08.17.97.85.76.06.56.35.55.56.16.16.57.37.16.94.44.44.54.47.77.98.28.87.98.58.69.15.55.65.96.18.5

Minority Interest

us-gaap:MinorityInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value118927976841080107465607570687272261819191935261413111099978-7-2-11-6-20-3-71
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.20.20.20.22.52.40.20.10.20.20.20.20.20.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0-0.0-0.0-0.0-0.0-0.00.0-0.0-0.00.0

Other Liabilities Noncurrent

us-gaap:OtherLiabilitiesNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value187310141100114211692835154715851574154622882443228222282111190718291747142214541474165316421836206118631268125812951369181514721533157314491550188615941309
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.62.62.93.03.16.53.53.73.53.45.36.06.15.75.65.25.34.93.94.04.14.44.75.25.95.33.73.84.04.05.34.64.84.74.44.76.05.14.8

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-312010-12-31
Value3078260633822780248098281307611555145271159214890141001403114007155891463715009145711522114670149191537317669179831833817631147651354112420
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.56.68.97.26.522.429.327.332.825.834.634.437.336.141.540.143.341.041.940.741.841.451.051.452.850.042.940.240.1

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value319726993462285725651090914150116201458711667149601416914103140801561514656150291459015240147051494615388176821799418348176401689615236149551477316056143071482213535150571427713934124129525
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.86.99.17.46.724.831.727.432.925.934.834.637.536.341.540.243.341.042.040.841.941.451.051.452.850.049.745.946.342.946.845.046.040.245.643.644.040.034.7

us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value-6885-6523-5734-5600-5687-5729-5440-6108-5437-5718-4609-4774-5064-5274-4580
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-215.4-241.7-165.6-196.0-221.7-52.5-38.4-52.6-37.3-49.0-30.8-33.7-35.9-37.5-31.4
Percentage of Assets-16.8-16.6-15.1-14.5-15.0-13.0-12.2-14.4-12.3-12.7-10.7-11.7-13.5-13.6-12.9
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Value6556668566086534575665836522582557585817575456865640555249634886479846353976
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest205.1247.7190.9228.7224.460.346.150.139.549.938.540.140.138.133.636.138.748.70.0
Percentage of Assets16.017.017.416.915.115.014.613.813.012.913.413.914.515.614.414.515.516.90.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-31
Value-6885-6523-5734-5600-5687-5740-5448-6108-5437-5694-4574-4742-5027-5225-4257-4371-4264-4580-3991
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-215.4-241.7-165.6-196.0-221.7-52.6-38.5-52.6-37.3-48.8-30.6-33.5-35.6-37.1-27.3-29.8-28.4-31.4-25.9
Percentage of Assets-16.8-16.6-15.1-14.5-15.0-13.1-12.2-14.4-12.3-12.7-10.6-11.6-13.4-13.5-11.3-12.0-12.3-12.9-10.7
Percentage of Assets us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-31
Value598598600603607661667673680687688688688691
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest18.722.217.321.123.76.14.75.84.75.94.64.94.94.7
Percentage of Assets1.51.51.61.61.61.51.51.61.51.51.61.71.81.9
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-31
Value118927976841080107465607570687219
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest3.73.42.32.73.39.97.60.60.40.60.50.50.50.1
Percentage of Assets0.30.20.20.20.22.52.40.20.10.20.20.20.20.1
Percentage of Assets us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Value5879492049814318487911395144081424716608138941614515590160461601116088148971273298307654
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest183.9182.3143.9151.1190.2104.5101.8122.6113.8119.1107.9110.0114.0109.7108.9110.1102.6103.20.0
Percentage of Assets14.312.513.111.212.826.032.333.637.430.937.538.141.445.046.844.341.135.80.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-312010-12-312009-12-312008-12-312007-12-31
Value-55-60-60-62-62-69-69-69-69-75-75-75-80-900000
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-1.7-2.3-1.8-2.2-2.4-0.6-0.5-0.6-0.5-0.6-0.5-0.5-0.6-0.60.00.00.00.0
Percentage of Assets-0.1-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.2-0.30.00.00.00.0
Percentage of Assets us-gaap:TreasuryStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value-4530-4638-3696-3763-3813-3852-3579-4160-4274-4311-3352
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-141.7-171.9-106.8-131.7-148.7-35.3-25.3-35.8-29.3-37.0-23.8
Percentage of Assets-11.0-11.8-9.8-9.7-10.0-8.8-8.0-9.8-9.6-9.6-8.6
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest us-gaap:SegmentContinuingOperations0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value-1804-1678-1762-1570-1601-1569-1584-1561-900-1191-1686
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-56.4-62.2-50.9-54.9-62.4-14.4-11.2-13.4-6.2-10.2-12.0
Percentage of Assets-4.4-4.3-4.6-4.1-4.2-3.6-3.6-3.7-2.0-2.6-4.3
Percentage of Assets us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest us-gaap:SegmentContinuingOperations0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value-556-211-282-271-268-238-225-228-231-234-210
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-17.4-7.9-8.2-9.5-10.5-2.2-1.6-2.0-1.6-2.0-1.5
Percentage of Assets-1.4-0.5-0.7-0.7-0.7-0.5-0.5-0.5-0.5-0.5-0.5
Percentage of Assets us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterest us-gaap:SegmentContinuingOperations0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value5464-3-22-17-18-51113224
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.20.20.20.2-0.1-0.2-0.1-0.2-0.31.01.6
Percentage of Assets0.00.00.00.0-0.0-0.1-0.0-0.0-0.10.30.6
Percentage of Assets us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterest us-gaap:SegmentContinuingOperations0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentDiscontinuedOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value00000-56-42-14019-71-200
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.0-0.5-0.3-1.20.1-0.6-1.4
Percentage of Assets0.00.00.00.00.0-0.1-0.1-0.30.0-0.2-0.5
Percentage of Assets us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest us-gaap:SegmentDiscontinuedOperations0.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value598598600603607661667673680687688688690688690690690691693693694694696699700698704704704716725725725724724724724721718
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.51.51.61.61.61.51.51.61.51.51.61.71.81.81.81.92.01.91.91.91.91.92.02.02.02.02.12.12.22.12.12.32.32.22.22.22.32.32.6

Additional Paid In Capital Common Stock

us-gaap:AdditionalPaidInCapitalCommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value655666856608653457566583652258255758581757545686561756405648558755235552544153685279529252225120503450505042496949024963491948904858488648384793473647984635
Percentage of AdditionalPaidInCapitalCommonStock100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets16.017.017.416.915.115.014.613.813.012.913.413.914.914.515.015.315.915.615.014.914.814.215.114.614.514.314.815.015.214.414.315.415.114.514.614.614.915.516.9

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value587949204981431848791139514408142471660813894161451559015876160461660115824161551601116856161141670616482174061720417665169921781116608164621608817062157361590614897151251388813785127329830
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets14.312.513.111.212.826.032.333.637.430.937.538.142.241.444.243.446.645.046.444.746.944.350.249.150.848.252.450.051.046.849.749.549.344.345.842.443.541.135.8

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value-6885-6523-5734-5600-5687-5729-5439-6108-5437-5718-4609-4774-5064-5274-4257-4371-4264-4580-4667-4403-4657-3991-2551-1935-1957-2002-3564-3948-4014-3797-3535-3934-3549-3858-2505-2009-2188-2670-2471
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-16.8-16.6-15.1-14.5-15.0-13.0-12.2-14.4-12.3-12.7-10.7-11.7-13.5-13.6-11.3-12.0-12.3-12.9-12.9-12.2-13.1-10.7-7.4-5.5-5.6-5.7-10.5-11.9-12.4-11.0-10.3-12.4-11.0-11.5-7.6-6.1-6.9-8.6-9.0

Treasury Stock Value

us-gaap:TreasuryStockValue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value5560606262696969697575757580808080909090909191919193939393192949494959595959698
Percentage of TreasuryStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.30.20.20.30.20.30.30.30.30.30.30.30.60.30.30.30.30.30.30.30.30.4

Minority Interest

us-gaap:MinorityInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value118927976841080107465607570687272261819191935261413111099978-7-2-11-6-20-3-71
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.20.20.20.22.52.40.20.10.20.20.20.20.20.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0-0.0-0.0-0.0-0.0-0.00.0-0.0-0.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value382196315101051311144821211517436174318811651339211616591401-3268041104948-841349169110532723798521176958
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues6.532.127.618.76.122.535.023.97.728.333.228.36.536.732.025.9-6.715.022.319.1-1.826.434.721.45.86.815.220.117.5

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value-1060-41-42361-7678-659-3983133-1701652-1758-2248-1429-1178-794-1020-145253-570182160-2178-1649-4683881355-652-40-52
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-18.1-0.7-7.71.1-150.8-10.2-6.649.3-3.026.8-31.1-38.6-27.3-20.5-15.3-18.9-3.04.7-11.53.73.5-42.5-33.8-9.58.324.2-11.6-0.7-1.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value106-1113-1692-8851367-1639432-831-3866-5425001059-875274-597579-816-679-595-943-7011628-405-702-595-1730-2057-713-547
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues1.8-18.2-30.9-15.726.9-25.57.1-13.1-67.8-8.88.818.2-16.74.8-11.510.7-16.8-12.6-12.0-18.9-15.131.8-8.3-14.2-12.7-30.9-36.7-12.2-10.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value382196315101051311144821211517436174318811651339211616591401-3268041104948-841349169110532723798521176958
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues6.532.127.618.76.122.535.023.97.728.333.228.36.536.732.025.9-6.715.022.319.1-1.826.434.721.45.86.815.220.117.5

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value1456149512531327424111251149-2591217-16565551008-11077177874744047879960052942850073372772712031206154882713269231011123611971055130213481248
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues24.924.522.923.583.317.519.0-4.121.4-26.99.817.3-2.113.415.013.89.08.916.112.111.48.410.314.915.512.520.820.327.613.924.416.518.020.119.118.123.023.522.8

Profit Loss

us-gaap:StatementEquityComponents

us-gaap:ProfitLoss

us-gaap:NoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value26124-1224-540160
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues0.40.20.1-0.00.40.1-0.10.10.00.30.0
Percentage of Revenues us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value1456149512531327424111251149-2591217-1656555
Percentage of ProfitLoss5559.212464.227258.7-120654.519106.326162.8-22105.8-6188.1304350.0-10227.8185200.0
Percentage of Revenues24.924.522.923.583.317.519.0-4.121.4-26.99.8
Percentage of Revenues us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.0

Depreciation Depletion And Amortization

us-gaap:DepreciationDepletionAndAmortization



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value273340288247356345415425422411372395386344392373385343358368357339342348348381385340299
Percentage of DepreciationDepletionAndAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Other Operating Capital Net

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value1408247802714-29366212701643-123-99518429-142926227-913473-80-9411048698-595-815
Percentage of IncreaseDecreaseInOtherOperatingCapitalNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Inventories

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value-1060-41-42361-7678-659-3983133-1701652-1758-2248-1429-1178-794-1020-145253-570182160-2178-1649-4683881355-652-40-52
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues-18.1-0.7-7.71.1-150.8-10.2-6.649.3-3.026.8-31.1-38.6-27.3-20.5-15.3-18.9-3.04.7-11.53.73.5-42.5-33.8-9.58.324.2-11.6-0.7-1.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value106-1113-1692-8851367-1639432-831-3866-5425001059-875274-597579-816-679-595-943-7011628-405-702-595-1730-2057-713-547
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Revenues1.8-18.2-30.9-15.726.9-25.57.1-13.1-67.8-8.88.818.2-16.74.8-11.510.7-16.8-12.6-12.0-18.9-15.131.8-8.3-14.2-12.7-30.9-36.7-12.2-10.0

Proceeds From Issuance Of Long Term Debt

us-gaap:ProceedsFromIssuanceOfLongTermDebt



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value02108004448024770000001206000227221820009920000
Percentage of ProceedsFromIssuanceOfLongTermDebt0.0100.00.00.0100.00.0100.00.00.00.00.00.00.0100.00.0100.00.0100.0100.00.00.00.0100.00.00.00.00.0

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value27622660060070201800000630000051195010031100201500540
Percentage of RepaymentsOfLongTermDebt100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:BusinessAcquisition

lly:DermiraInc.



Period End2020-03-31
Value276
Percentage of RepaymentsOfLongTermDebt100.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.0
Percentage of LongTermDebtAndCapitalLeaseObligations lly:DermiraInc.0.0

Payments Of Dividends

us-gaap:PaymentsOfDividends



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value671587587598637572572579587548547548547541537541538533526539527525525526524531544543539
Percentage of PaymentsOfDividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Payments Of Dividends

us-gaap:PaymentsOfDividends



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value671587587598637572572579587548547548547541537541538533526539527525525526524531544543539
Percentage of PaymentsOfDividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Payments For Repurchase Of Common Stock

us-gaap:PaymentsForRepurchaseOfCommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-31
Value5003006000350011001000950110099019906000300252611243103003001455511980
Percentage of PaymentsForRepurchaseOfCommonStock100.0100.0100.00.0100.0100.0100.0100.0100.0100.00.0100.00.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value27622660060070201800000630000051195010031100201500540
Percentage of RepaymentsOfLongTermDebt100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:BusinessAcquisition

lly:DermiraInc.



Period End2020-03-31
Value276
Percentage of RepaymentsOfLongTermDebt100.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.0
Percentage of LongTermDebtAndCapitalLeaseObligations lly:DermiraInc.0.0

Debt Instrument Interest Rate Stated Percentage

Effective Income Tax Rate Continuing Operations

us-gaap:EffectiveIncomeTaxRateContinuingOperations



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302016-09-30
Value0.1330.1080.0950.2330.1850.193000000000000030.1450.0610.199
Percentage of EffectiveIncomeTaxRateContinuingOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

Share Based Compensation

us-gaap:ShareBasedCompensation



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value7181757975726870687269696966616562585455484038383835283773
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Liabilities

Deferred Tax Assets Net

Unrecognized Tax Benefits

Deferred Tax Assets Valuation Allowance

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

Operating Lease Right Of Use Asset

Cash And Cash Equivalents Period Increase Decrease

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents



Period End2020-03-312019-12-312019-03-31
Value169923372036
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0

Proceeds From Repayments Of Short Term Debt

Proceeds From Sale Of Short Term Investments

us-gaap:ProceedsFromSaleOfShortTermInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-31
Value362026533517382046450253264250911683963204035215763007785071392771722116616071070
Percentage of ProceedsFromSaleOfShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Proceeds From Sale Of Longterm Investments

us-gaap:ProceedsFromSaleOfLongtermInvestments



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-03-31
Value54823328349308431057957952868758033852111545961815290626332098
Percentage of ProceedsFromSaleOfLongtermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:AcquiredInProcessResearchAndDevelopment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-12-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-312010-03-31
Value52077251363293016240502050857300001990802561059500575700000000388005050
Percentage of AcquiredInProcessResearchAndDevelopment100.00.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.00.00.00.0100.00.0100.0100.0100.0100.00.00.0100.00.00.00.00.00.00.00.00.0100.00.00.0100.0

us-gaap:BusinessAcquisition

lly:SitryxTherapeuticsLimited



Period End2020-03-31
Value52
Percentage of AcquiredInProcessResearchAndDevelopment100.0

lly:AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value117171323052
Percentage of AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0106010471
Percentage of AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService, us-gaap:TypeOfArrangement

lly:CollaborativeArrangementRightsAndObligationsTerms

lly:Basaglar, lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulative



Period End2020-03-312019-12-312019-09-302019-06-302019-03-31
Value-250000-250
Percentage of CollaborativeArrangementRightsAndObligationsTerms100.00.00.00.0100.0

lly:Jardiance, lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulative



Period End2020-03-312019-12-312019-09-302019-06-302019-03-31
Value289000289
Percentage of CollaborativeArrangementRightsAndObligationsTerms-115.60.00.00.0-115.6

lly:Lebrikizumab, lly:MilestonePaymentsDevelopmentAndRegulatory



Period End2020-03-31
Value85
Percentage of CollaborativeArrangementRightsAndObligationsTerms-34.0

lly:Lebrikizumab, lly:MilestonePaymentsSalesBased



Period End2020-03-31
Value1250
Percentage of CollaborativeArrangementRightsAndObligationsTerms-500.0

lly:Olumiant, lly:MilestonePaymentsDevelopmentAndRegulatory



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312009-12-31
Value1300001300-20-100250295
Percentage of CollaborativeArrangementRightsAndObligationsTerms-52.00.00.00.0-52.00.00.00.00.00.0

lly:Olumiant, lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulative



Period End2020-03-31
Value180
Percentage of CollaborativeArrangementRightsAndObligationsTerms-72.0

lly:Olumiant, lly:MilestonePaymentsSalesBased



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312009-12-31
Value150000150000150150
Percentage of CollaborativeArrangementRightsAndObligationsTerms-60.00.00.00.0-60.00.00.00.00.00.0

lly:Tanezumab, lly:MilestonePaymentsDevelopmentAndRegulatory



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-10-31
Value350000350000350350
Percentage of CollaborativeArrangementRightsAndObligationsTerms-140.00.00.00.0-140.00.00.00.00.00.0

lly:Tanezumab, lly:MilestonePaymentsSalesBased



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-10-31
Value1230000123000012301230
Percentage of CollaborativeArrangementRightsAndObligationsTerms-492.00.00.00.0-492.00.00.00.00.00.0

lly:TrajentaBI, lly:MilestonePaymentsDevelopmentandRegulatoryCapitalizedDeferredCumulative



Period End2020-03-312019-12-312019-09-302019-06-302019-03-31
Value446000446
Percentage of CollaborativeArrangementRightsAndObligationsTerms-178.60.00.00.0-178.6

us-gaap:ProductOrService, us-gaap:TypeOfArrangement, dei:LegalEntity

lly:Lebrikizumab, lly:MilestonePaymentsDevelopmentAndRegulatory, lly:Roche



Period End2020-03-31
Value180
Percentage of CollaborativeArrangementRightsAndObligationsTerms-72.0

lly:Lebrikizumab, lly:MilestonePaymentsSalesBased, lly:Roche



Period End2020-03-31
Value1030
Percentage of CollaborativeArrangementRightsAndObligationsTerms-412.0

lly:CostOfSalesOperatingExpensesAndOtherNet



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value4179445040704170436154994650635042595876506645635167486842214460429849313911429940264607422039953792425944143650356844154266464547214565398340123777
Percentage of CostOfSalesOperatingExpensesAndOtherNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:DerivativeInstrumentsGainLossRecognized



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1442-55452202-4-6220
Percentage of DerivativeInstrumentsGainLossRecognized100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:ProceedsfromSaleofEquityandAvailableforSaleSecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value63113853629369524953592
Percentage of ProceedsfromSaleofEquityandAvailableforSaleSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:PurchasedInProcessResearchAndDevelopment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-12-31
Value1307745196229301548050205083100050136200450057
Percentage of PurchasedInProcessResearchAndDevelopment100.00.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.00.00.00.0100.0100.0100.0100.00.00.0100.0

us-gaap:StatementGeographical, us-gaap:ChangeInAccountingEstimateByType

lly:RevenueInformationUsedToDetermineRevenueRecognizedChangeInAccountingEstimatePercent

country:US, us-gaap:SalesReturnsAndAllowances



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0.02-0.0099999999999999980.020.040.03-0.010.010.010.04
Percentage of RevenueInformationUsedToDetermineRevenueRecognizedChangeInAccountingEstimatePercent100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AssetImpairmentCharges



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-312016-09-302016-06-302015-12-312015-09-302015-06-302014-12-312014-09-302014-06-30
Value5070004277888049131235573738693050212190
Percentage of AssetImpairmentCharges100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:BusinessAcquisition

lly:LoxoOncologyInc.



Period End2020-03-312019-12-312019-09-302019-06-302019-03-31
Value400000400
Percentage of AssetImpairmentCharges799.80.00.00.093.7

us-gaap:BusinessAcquisition

us-gaap:BusinessCombinationConsiderationTransferred1

lly:DermiraInc.



Period End2020-02-20
Value849
Percentage of BusinessCombinationConsiderationTransferred1100.0

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect



Period End2020-03-312019-03-31
Value-638500000.0-5961800000.0
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1

us-gaap:InterestRateContract, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value117-36495939135-19-19-5410-415-7-61-183575-1366-9958
Percentage of ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1

lly:HedgedFixedRateDebt, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value-11736-49-59-39-135191954-104-1576118-35-7513-6699-58
Percentage of ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value-800000.0-400000.0-400000.0-500000.0-800000.0-2200000.0-2400000.0-4600000.0-5100000.0-4100000.0
Percentage of DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value-111000000.0-70900000.0-73100000.0-69600000.0-79200000.0-91600000.0-90400000.0-72500000.0-70400000.0-72700000.0
Percentage of DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit13875.017725.018275.013920.09900.04163.63766.71576.11380.41773.2

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value-14-15-15-15-19-20-20-22-22-22-21
Percentage of DefinedBenefitPlanAmortizationOfPriorServiceCostCredit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value111111111111132
Percentage of DefinedBenefitPlanAmortizationOfPriorServiceCostCredit-7.40.0-9.6-9.6-9.60.0-5.7-6.4-5.90.0-6.2-6.7-6.20.0-13.5

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value3735363644434340404037
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value221209208210211212212211212190196195194185187
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets591.40.0581.9583.6586.40.0474.8481.1484.10.0488.6487.0481.40.0498.9

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanInterestCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value1114141414131313131313
Percentage of DefinedBenefitPlanInterestCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value105121121122120118117112112104103103102106104
Percentage of DefinedBenefitPlanInterestCost954.50.0834.5851.4826.70.0791.3829.6810.10.0784.8770.1787.70.0801.5

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value-30-27-27-27-67-37-37-33-32-34-31
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value7449465042526171724786766616160
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost-243.00.0-169.9-184.0-152.90.0-90.2-189.4-192.80.0-201.5-207.2-178.00.0-194.6

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanServiceCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-30
Value99981010101112119
Percentage of DefinedBenefitPlanServiceCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value786262636171747780798686786570
Percentage of DefinedBenefitPlanServiceCost803.10.0685.7675.5702.30.0734.7712.8751.40.0741.4722.5704.50.0723.7

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents



Period End2020-03-312019-03-31
Value-6637
Percentage of EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0

us-gaap:EquitySecuritiesFvNiGainLoss



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value164-57726614923-402018
Percentage of EquitySecuritiesFvNiGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments

us-gaap:ForeignExchangeContract, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value531-528-481760-59-16177-16-25-37184-1-90-13-21141-23
Percentage of GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:GainLossOnSaleOfBusiness



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value0003680000
Percentage of GainLossOnSaleOfBusiness0.00.00.0100.00.00.00.0

us-gaap:DisposalGroupClassification, us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperations

us-gaap:DiscontinuedOperationsDisposedOfBySale, lly:ElancoAnimalHealthIncorporated



Period End2020-03-312019-09-302019-06-302019-03-31
Value3700003700
Percentage of GainLossOnSaleOfBusiness0.00.00.0100.5

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value00003680355-2850
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTax0.00.00.00.0100.0100.0100.0100.0100.0

us-gaap:DisposalGroupClassification, us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperations

us-gaap:DiscontinuedOperationsDisposedOfBySale, lly:ElancoAnimalHealthIncorporated



Period End2020-03-312019-12-312019-09-302018-12-312018-09-30
Value368000355
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTax0.00.00.097.3100.0

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0000-84-1100
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTax0.00.00.00.0-2.3-51.42.12.5-1.4

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0.00.00.00.03.760.00.06-0.030.05
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare0.00.00.00.0100.00.0100.0100.0100.0

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0.00.00.00.03.740.00.05-0.030.05
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare0.00.00.00.0100.00.0100.0100.0100.0

us-gaap:IncreaseDecreaseInDeferredIncomeTaxes



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value-11-8512-6172-165-26-15722939-446166128-790182138301419-4-559-107-14863279351-132-92-230
Percentage of IncreaseDecreaseInDeferredIncomeTaxes100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InvestmentIncomeInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value14131719304232414552453632312923242321202124283334322923252726221715161110
Percentage of InvestmentIncomeInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LitigationCase, us-gaap:StatementGeographical

us-gaap:LossContingencyDamagesAwardedValue

lly:EmployeeLitigation, country:BR



Period End2020-03-312019-09-302019-07-312019-06-302019-03-312018-12-312018-09-302018-07-312018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-09-302014-06-30
Value95120500130130375-135500-40300-15-685685315-50302800001000450450
Percentage of LossContingencyDamagesAwardedValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.00.00.0100.0100.0100.0

us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value-44600000.0-52000000.0-52200000.0-49800000.0-55900000.0-66300000.0-62900000.0-54900000.0-56000000.0-57700000.0-63800000.0-64300000.0
Percentage of NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value-442-772-18137-80-341610-700324-474141257189-101373-1562008-226223-709-616223302-11-291
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value30-986213-5-31653255-20
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax-7.0127.8-11.79.27.192.887.3-8.0-6.4

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-126146-19231-3114-23-661291
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax28.6-18.9105.684.639.3-4.4-3.894.489.8

us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-348-12-6-32-16000
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax78.67.0-16.440.84.80.0-0.0-0.0

us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value121816-6165-36
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax-0.2-0.3-0.822.6-20.81.90.2-9.4-11.1

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentDiscontinuedOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0000-27-1699-16090
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax-0.0-0.0-0.00.033.74.916.323.027.7

us-gaap:DerivativeInstrumentRisk

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax

us-gaap:CrossCurrencyInterestRateContract



Period End2020-03-312019-12-312019-09-302019-03-31
Value-691216-30
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax100.0100.0100.0100.0

us-gaap:InterestRateSwap



Period End2020-03-312019-12-312019-09-302019-03-31
Value-36976-32-11
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax529.8608.0-197.039.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax

us-gaap:CrossCurrencyInterestRateContract, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-03-31
Value-12-28
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax100.0100.0

us-gaap:InterestRateContract, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-03-31
Value4523
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax-31.00.00.0-13.4

us-gaap:DerivativeInstrumentRisk

us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax

lly:HedgedFixedRateDebt



Period End2020-03-312019-09-302019-03-31
Value678953
Percentage of OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax100.0100.0100.0

us-gaap:CrossCurrencyInterestRateContract



Period End2020-03-312019-12-312019-09-302019-03-31
Value115-758938
Percentage of OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax171.80.099.771.3

us-gaap:OtherComprehensiveIncomeLossNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-31
Value-362-789-1348752-291660-671386-476167284198-968113-10631686-263254-665-1440-616224538465-217398-385309-496178481
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value108-941665039-27358111436
Percentage of OtherComprehensiveIncomeLossNetOfTax-29.9119.3-49.657.974.093.888.0-17.09.6

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-12684-19231-3114-23-661291
Percentage of OtherComprehensiveIncomeLossNetOfTax34.9-10.6143.336.1-60.2-5.1-3.598.575.5

us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-345-10-2-29-13232
Percentage of OtherComprehensiveIncomeLossNetOfTax95.27.8-3.3-56.74.60.4-0.40.7

us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0-12818-4032-35
Percentage of OtherComprehensiveIncomeLossNetOfTax-0.20.2-1.69.335.11.70.1-4.9-9.2

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentDiscontinuedOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value000056-1498-16090
Percentage of OtherComprehensiveIncomeLossNetOfTax-0.0-0.0-0.00.0107.85.014.923.923.5

us-gaap:StatementOperatingActivitiesSegment

us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-362-789-13487-4-277561-511295
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0-7.895.085.176.176.5

us-gaap:SegmentDiscontinuedOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value000056-1498-16090
Percentage of OtherComprehensiveIncomeLossNetOfTax-0.0-0.0-0.00.0107.85.014.923.923.5

us-gaap:OtherComprehensiveIncomeLossTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-30
Value-27-20620727-17214691-35-260-19-85-38-732258313433854-4522-2
Percentage of OtherComprehensiveIncomeLossTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value25-226171311-1051522314-210968
Percentage of OtherComprehensiveIncomeLossTax-94.5109.785.7178.741.560.9104.125.8-40.681.0-49.5-7.1-22.4

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value3815-719-62-758-40-21-33-86-29
Percentage of OtherComprehensiveIncomeLossTax-141.5-0.625.1-97.370.236.4-4.863.7113.98.1178.4100.578.2

us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value-9118-20-8-30001151
Percentage of OtherComprehensiveIncomeLossTax337.1-9.1-13.3-9.3-29.12.10.50.8-2.3-0.5-6.8-6.8-3.4

us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value00024-108-10-294-11-18
Percentage of OtherComprehensiveIncomeLossTax-1.1-0.02.528.017.50.60.19.729.011.4-22.113.447.6

us-gaap:OtherOperatingActivitiesCashFlowStatement



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value-7419374113-3215113716221752271343836051184227-129-11-49138306759-6-7-54
Percentage of OtherOperatingActivitiesCashFlowStatement100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsForProceedsFromOtherInvestingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-312010-03-31
Value-51-232141-4638521432421376110975543-4363041592-2518191118503410
Percentage of PaymentsForProceedsFromOtherInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-03-312012-03-312011-03-31
Value8490006917000000088200450-4110527600551001950
Percentage of PaymentsToAcquireBusinessesNetOfCashAcquired100.00.00.00.0100.00.00.00.00.00.00.00.0100.00.00.0100.00.0100.0100.00.0100.00.00.0100.00.00.0100.00.0

us-gaap:PaymentsToAcquireLongtermInvestments



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-06-302013-03-31
Value8350866043114561138014129451371155271684090892430422824277046141861
Percentage of PaymentsToAcquireLongtermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireProductiveAssets



Period End2020-03-312019-03-31
Value258203
Percentage of PaymentsToAcquireProductiveAssets100.0100.0

us-gaap:PaymentsToAcquireShortTermInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-03-312012-03-31
Value0800330001124151090159428916016698175422165597401402313612
Percentage of PaymentsToAcquireShortTermInvestments0.0100.00.0100.0100.00.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-03-312011-03-312010-03-31
Value-194-40-1-193-58-83-54-176-64-52-51-195-179-59-8523111-5-124578117-1-60000000
Percentage of ProceedsFromPaymentsForOtherFinancingActivities100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.00.0100.0100.0

us-gaap:ProceedsFromShortTermDebt



Period End2020-03-312019-03-31
Value17481850
Percentage of ProceedsFromShortTermDebt100.0100.0

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value-8017-47-49-133-49-49-29-612-26-27-8-45-40-49-115-7837-30-44600-19-21-82-77-74
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-30
Value-80-47-49-133-49-29
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax100.0100.0100.0100.0100.0100.0

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents

us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-30
Value-77-45-47-44-48-58
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax96.194.294.233.597.0200.7

us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-77-44-45-47-44-43-48-58-57
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax96.1-264.194.294.233.586.997.0200.793.5

us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0620000000
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax-0.0365.3-0.0-0.0-0.0-0.0-0.0-0.0-0.0

us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-3-2-3-3-3-2-2-2
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax4.04.66.42.26.05.89.94.7

us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentContinuingOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0300-1-10330
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax-0.122.91.3-0.61.33.2-0.4-113.00.6

us-gaap:AociIncludingPortionAttributableToNoncontrollingInterest, us-gaap:SegmentDiscontinuedOperations



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0000-84-1100
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax-0.00.0-0.0-0.063.03.8-2.42.41.1

us-gaap:RestructuringSettlementAndImpairmentProvisions



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value591510042324683747810034065021314745581311444272108401360313506321204530232513276592726
Percentage of RestructuringSettlementAndImpairmentProvisions100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:SeveranceCosts1



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-30
Value98100-3167-5-277358171-116889819975122231189170
Percentage of SeveranceCosts1100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value20002000200
Percentage of StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value0000000000
Percentage of StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans-1.70.0-110.00.0-2.20.00.00.0-2.30.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

us-gaap:AdditionalPaidInCapital



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-201-5-1-1-202-80-2-127-9-1
Percentage of StockIssuedDuringPeriodValueEmployeeStockPurchasePlan100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value1000100010
Percentage of StockIssuedDuringPeriodValueEmployeeStockPurchasePlan-0.8-2.0-0.0-0.0-0.9-1.2-0.0-0.0-1.3-1.1

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value5010700060
Percentage of StockIssuedDuringPeriodValueEmployeeStockPurchasePlan-2.5-0.0-100.0-0.0-3.6-0.0-0.04.0-5.1-0.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation

us-gaap:AdditionalPaidInCapital



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value7181757975726870687269
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:StockholdersEquityOther

us-gaap:RetainedEarnings



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-30
Value0-613-1359-30
Percentage of StockholdersEquityOther100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:TreasuryStockRetiredCostMethodAmount

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value21335566780
Percentage of TreasuryStockRetiredCostMethodAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetainedEarnings



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value497298596696107711093993943109199
Percentage of TreasuryStockRetiredCostMethodAmount21639.117547.118078.820488.219339.017641.915526.612921.912400.014171.4

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value-500-300-600-700-10827-1100-1000-950-1100-99
Percentage of TreasuryStockRetiredCostMethodAmount-21739.1-17647.1-18181.8-20588.2-19439.0-17741.9-15625.0-13023.3-12500.0-14271.4

us-gaap:StatementEquityComponents

us-gaap:TreasuryStockSharesAcquired

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value3255-2481-1011147
Percentage of TreasuryStockSharesAcquired100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:TreasuryStockSharesRetired

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value32558991011141
Percentage of TreasuryStockSharesRetired100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value32558991011141
Percentage of TreasuryStockSharesRetired100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:TreasuryStockValueAcquiredCostMethod

us-gaap:TreasuryStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value500300600700280011001000950110099
Percentage of TreasuryStockValueAcquiredCostMethod100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

lly:DebtSecuritiesAvailableforsaleUnrealizedGainPosition



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value297429476441338841641481434
Percentage of DebtSecuritiesAvailableforsaleUnrealizedGainPosition100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LitigationCase, us-gaap:SubsequentEventType

lly:LossContingencyNumberOfPatents

lly:EmgalityPatentLitigation, us-gaap:SubsequentEvent



Period End2020-02-19
Value9.0
Percentage of LossContingencyNumberOfPatents100.0

lly:SalesRebatesAndDiscounts



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value470349335277499344555021512947454348446543324029369739143547309826012560254123282025206819701875172419412014179716931777169516281619177118821807148913721109
Percentage of SalesRebatesAndDiscounts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccruedIncomeTaxesNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value362136073526348537603724374035063748377671070569768880580590886891010269549989329409061078853141013631334127512071158108610581283122412341088
Percentage of AccruedIncomeTaxesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value23222223243234354038424041404439454447484955555961100106107107108111108108110126116112100109
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312015-09-302015-06-302014-12-31
Value1110129502118454204171
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312015-09-302015-06-302014-12-31
Value34441029242547381818
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:CashAndCashEquivalentsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value417102527398280657526646518815004712161111469162699161416121637
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value0000000005145552173287137
Percentage of CashAndCashEquivalentsFairValueDisclosure0.00.00.00.00.00.00.00.00.01.128.345.48.010.60.10.20.5

us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value4171025273982806575266465188150047632066166799029861615161516442443
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0101.1128.3145.4108.0110.6100.1100.2100.50.0

us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value4171025273982806575266465188150047632066166799029861615161516442443
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0101.1128.3145.4108.0110.6100.1100.2100.50.0

us-gaap:PortionAtOtherThanFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value417102527398280657526646518815004763206616679902986161516151644
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0101.1128.3145.4108.0110.6100.1100.2100.5

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis

us-gaap:CommercialPaper

us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
Value323914911550204923424973982445149226902523142317981299
Percentage of CommercialPaper100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-312014-12-31
Value32431494155720582349498399244814942696252614251799129902680
Percentage of CommercialPaper100.1100.2100.5100.4100.3100.3100.3100.1100.1100.2100.1100.1100.1100.00.00.0

us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-312014-12-31
Value32391491155020492342497398244514922690252314231798129902680
Percentage of CommercialPaper100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

us-gaap:CommonStockSharesHeldInEmployeeTrust



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value301330133013301330133013301330133013301330133013301330133013301330133013301330133013301330133013301330133013301330133013301330133013301330133013301330103010
Percentage of CommonStockSharesHeldInEmployeeTrust100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiability



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value307264272277286299308315324335
Percentage of ContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService

lly:Lebrikizumab



Period End2020-03-31
Value43
Percentage of ContractWithCustomerLiability14.2

us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value631411692555788588168984692
Percentage of DebtSecuritiesAvailableForSaleUnrealizedLossPosition100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxAssetsNet



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value2471257224122507251126571166
Percentage of DeferredIncomeTaxAssetsNet100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxLiabilitiesNet



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value218621872413238023991312
Percentage of DeferredIncomeTaxLiabilitiesNet100.0100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlans

us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsInFiveFiscalYearsThereafter

lly:OtherPostretirementBenefitPlansDefinedBenefitGross



Period End2020-12-312011-12-31
Value787790
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsInFiveFiscalYearsThereafter100.0100.0

lly:OtherPostretirementBenefitPlansDefinedBenefitPlansMedicareRebates



Period End2020-12-312011-12-31
Value-98-91
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsInFiveFiscalYearsThereafter-12.5-11.6

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-12-312011-12-31
Value688699
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsInFiveFiscalYearsThereafter87.588.4

us-gaap:PensionPlansDefinedBenefit



Period End2020-12-312011-12-31
Value24662609
Percentage of DefinedBenefitPlanExpectedFutureBenefitPaymentsInFiveFiscalYearsThereafter313.3329.9

us-gaap:DerivativeInstrumentRisk

us-gaap:DerivativeAssetNotionalAmount

lly:BuyBritishPoundandSellUSDollars



Period End2020-03-312019-09-302019-06-302019-03-312018-09-30
Value210158299409613
Percentage of DerivativeAssetNotionalAmount100.0100.0100.0100.0100.0

lly:BuyEuroSellUsDollar



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value1750202014101280223023501840126022903360878139037502240200018201540
Percentage of DerivativeAssetNotionalAmount832.10.0890.2427.1545.10.0300.20.00.00.00.00.00.00.00.00.00.0

lly:BuyUSdollarSellJapaneseYen



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value3126033490416503022039580488504794043670451504441047900602906596070440754207207071730
Percentage of DerivativeAssetNotionalAmount14864.50.026294.210083.49674.90.07820.60.00.00.00.00.00.00.00.00.00.0

lly:BuyUsDollarSellEuro



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value8561130535108011901530122042211903890844633531
Percentage of DerivativeAssetNotionalAmount407.2713.4178.8264.0194.10.00.00.00.00.00.00.00.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:DerivativeAssetsCurrent

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-09-302019-06-302019-03-312018-12-31
Value1847166069
Percentage of DerivativeAssetsCurrent100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-09-302019-06-302019-03-312018-12-31
Value1847166069
Percentage of DerivativeAssetsCurrent100.0100.0100.0100.0100.0

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-09-302019-06-302019-03-312018-12-31
Value1847166069
Percentage of DerivativeAssetsCurrent100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:ForeignExchangeContract, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value14189171111611526212883182013
Percentage of DerivativeAssetsCurrent80.60.019.3104.118.416.30.00.00.00.00.00.00.00.00.00.00.0

us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:ForeignExchangeContract, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value141891711116115262128831820139
Percentage of DerivativeAssetsCurrent80.60.019.3104.118.416.30.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ForeignExchangeContract, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value141891711116115262128831820139
Percentage of DerivativeAssetsCurrent80.60.019.3104.118.416.30.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:DerivativeAssetsNoncurrent

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value116457626268
Percentage of DerivativeAssetsNoncurrent100.0100.0100.0100.0100.0100.0

us-gaap:InterestRateContract, us-gaap:CashFlowHedging, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-31
Value043
Percentage of DerivativeAssetsNoncurrent-0.496.0

us-gaap:InterestRateContract, us-gaap:FairValueHedging, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value1897211882304
Percentage of DerivativeAssetsNoncurrent163.0159.6154.8312.1114.954.9

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value116457626268
Percentage of DerivativeAssetsNoncurrent100.0100.0100.0100.0100.0100.0

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value116457626268
Percentage of DerivativeAssetsNoncurrent100.0100.0100.0100.0100.0100.0

us-gaap:InterestRateContract, us-gaap:CashFlowHedging, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-31
Value043
Percentage of DerivativeAssetsNoncurrent-0.496.0

us-gaap:InterestRateContract, us-gaap:CashFlowHedging, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-31
Value043
Percentage of DerivativeAssetsNoncurrent-0.496.0

us-gaap:InterestRateContract, us-gaap:FairValueHedging, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value1897211882304
Percentage of DerivativeAssetsNoncurrent163.0159.6154.8312.1114.954.9

us-gaap:InterestRateContract, us-gaap:FairValueHedging, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value1897211882304
Percentage of DerivativeAssetsNoncurrent163.0159.6154.8312.1114.954.9

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:DerivativeLiabilitiesCurrent

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-06-302019-03-312018-12-31
Value121359
Percentage of DerivativeLiabilitiesCurrent100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-06-302019-03-312018-12-31
Value121359
Percentage of DerivativeLiabilitiesCurrent100.0100.0100.0100.0100.0

us-gaap:CrossCurrencyInterestRateContract, us-gaap:NetInvestmentHedging, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-06-302019-03-312018-12-31
Value121359
Percentage of DerivativeLiabilitiesCurrent100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:ForeignExchangeContract, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value2411101128161495361321492157217
Percentage of DerivativeLiabilitiesCurrent1366.755.60.0325.0576.0177.20.00.00.00.00.00.00.00.00.00.00.0

us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:ForeignExchangeContract, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value241110112816149536132149215721714
Percentage of DerivativeLiabilitiesCurrent1366.755.60.0325.0576.0177.20.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ForeignExchangeContract, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312014-12-31
Value241110112816149536132149215721714
Percentage of DerivativeLiabilitiesCurrent1366.755.60.0325.0576.0177.20.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:DerivativeLiabilitiesNoncurrent

us-gaap:CrossCurrencyInterestRateContract, us-gaap:CashFlowHedging, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value742049192725
Percentage of DerivativeLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0

us-gaap:InterestRateContract, us-gaap:CashFlowHedging, us-gaap:FairValueInputsLevel2, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-09-30
Value32732
Percentage of DerivativeLiabilitiesNoncurrent441.365.7

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:FairValueByMeasurementBasis, us-gaap:HedgingDesignation

us-gaap:CrossCurrencyInterestRateContract, us-gaap:CashFlowHedging, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value742049192725
Percentage of DerivativeLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0

us-gaap:CrossCurrencyInterestRateContract, us-gaap:CashFlowHedging, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value742049192725
Percentage of DerivativeLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0

us-gaap:InterestRateContract, us-gaap:CashFlowHedging, us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-09-30
Value32732
Percentage of DerivativeLiabilitiesNoncurrent441.365.7

us-gaap:InterestRateContract, us-gaap:CashFlowHedging, us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-09-30
Value32732
Percentage of DerivativeLiabilitiesNoncurrent441.365.7

us-gaap:DerivativeInstrumentRisk

us-gaap:DerivativeLiabilityNotionalAmount

lly:BuyBritishPoundandSellUSDollars



Period End2020-03-312019-09-302019-06-302019-03-312018-09-30
Value168127237309466
Percentage of DerivativeLiabilityNotionalAmount100.0100.0100.0100.0100.0

lly:BuyEuroSellUsDollar



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value1570181012801140197020501570108018602830735124034702130179016101390
Percentage of DerivativeLiabilityNotionalAmount934.00.01006.3479.8636.10.0336.60.00.00.00.00.00.00.00.00.00.0

lly:BuyUSdollarSellJapaneseYen



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value291308386279356435426396425393428540587609742686637
Percentage of DerivativeLiabilityNotionalAmount173.20.0303.9117.6115.20.091.50.00.00.00.00.00.00.00.00.00.0

lly:BuyUsDollarSellEuro



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value9461250605122014001770150050213404160946707598
Percentage of DerivativeLiabilityNotionalAmount562.9982.7254.8393.9300.20.00.00.00.00.00.00.00.0

us-gaap:DerivativeInstrumentRisk

us-gaap:DerivativeNotionalAmount

lly:SwapU.S.DollarsToBritishPounds



Period End2020-03-312019-09-30
Value396268
Percentage of DerivativeNotionalAmount100.0100.0

lly:SwapU.S.DollarsToEuro



Period End2020-03-312019-09-30
Value23501930
Percentage of DerivativeNotionalAmount593.4720.1

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

us-gaap:InterestRateSwap, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-09-30
Value17501000
Percentage of DerivativeNotionalAmount441.9373.1

us-gaap:EmployeeRelatedLiabilitiesCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value5659157045885111054858710588997821668566896738622548967829672518759701633554943805671543940772602533804689584524851894
Percentage of EmployeeRelatedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis, us-gaap:FinancialInstrument

us-gaap:EquitySecuritiesFvNi

us-gaap:FairValueInputsLevel1, us-gaap:EstimateOfFairValueFairValueDisclosure, lly:MarketableSecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value869718483466502357287315
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel3, us-gaap:EstimateOfFairValueFairValueDisclosure, lly:OtherEquitySecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value606083828287137136
Percentage of EquitySecuritiesFvNi6.98.317.317.616.424.647.743.1

us-gaap:FairValueByMeasurementBasis, us-gaap:FinancialInstrument

us-gaap:CarryingReportedAmountFairValueDisclosure, lly:MarketableSecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value869718483466502357287315
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CarryingReportedAmountFairValueDisclosure, lly:OtherEquitySecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value606083828287137136
Percentage of EquitySecuritiesFvNi6.98.317.317.616.424.647.743.1

us-gaap:EstimateOfFairValueFairValueDisclosure, lly:MarketableSecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value869718483466502357287315
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EstimateOfFairValueFairValueDisclosure, lly:OtherEquitySecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value606083828287137136
Percentage of EquitySecuritiesFvNi6.98.317.317.616.424.647.743.1

us-gaap:PortionAtOtherThanFairValueFairValueDisclosure, lly:MarketableSecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value250254235228238238146133
Percentage of EquitySecuritiesFvNi28.835.448.648.947.566.750.942.3

us-gaap:PortionAtOtherThanFairValueFairValueDisclosure, lly:OtherEquitySecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value2727384029293939
Percentage of EquitySecuritiesFvNi3.23.87.98.65.98.313.712.4

us-gaap:FairValueByMeasurementBasis

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312018-12-31
Value426405414
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount100.0100.0100.0

us-gaap:FairValueByMeasurementBasis, us-gaap:FinancialInstrument

us-gaap:OtherLongTermInvestments

us-gaap:CarryingReportedAmountFairValueDisclosure, lly:EquityMethodAndOtherInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value348299273283275304275255584
Percentage of OtherLongTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherReceivablesNetCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Value124699410969779771182793756775715613606596736672545564558665747683566581566743588550634589552
Percentage of OtherReceivablesNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PrepaidExpenseCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value276125382369231522272146187916881570144710631010821734756789792604762730797811821108511117558539889878227909539986547998671140608592
Percentage of PrepaidExpenseCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
Value687678682696638696645673680723678687652661685731670
Percentage of TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value4020410022802360233026503700
Percentage of TranslationAdjustmentForNetInvestmentHedgeNetOfTax100.0100.0100.0100.0100.0100.0100.0

Line plots across dimensions of each concept

us-gaap:SharesIssued us-gaap:StatementEquityComponents


us-gaap:Revenues us-gaap:ProductOrService


us-gaap:Revenues us-gaap:StatementGeographical


us-gaap:Revenues us-gaap:ProductOrService, us-gaap:StatementGeographical


us-gaap:OtherNonoperatingIncomeExpense us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncome, us-gaap:StatementEquityComponents


us-gaap:ProfitLoss us-gaap:StatementEquityComponents


us-gaap:LongTermDebt us-gaap:FairValueByMeasurementBasis


us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents


us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents, us-gaap:StatementOperatingActivitiesSegment


us-gaap:ProfitLoss us-gaap:StatementEquityComponents